C. Brophy Christensen, Esq.
Jeeho M. Lee, Esq.
O’Melveny & Myers LLP
Times Square Tower
7 Times Square
New York, New York 10036
(212) 326-2000
|
| |
Christopher Bellini, Esq.
Seth Popick, Esq.
Cozen O’Connor P.C.
33 South 6th Street, Suite 3800
Minneapolis, Minnesota 55402
(612) 260-9000
|
Large accelerated filer
|
| |
☐
|
| |
|
| |
Accelerated filer
|
| |
☐
|
Non-accelerated filer
|
| |
☒
|
| |
|
| |
Smaller reporting company
|
| |
☐
|
|
| |
|
| |
|
| |
Emerging growth company
|
| |
☒
|
Title of Each Class of
Securities to be Registered
|
| |
Proposed Maximum
Aggregate Offering
Price(1)(2)
|
| |
Amount of
Registration Fee
|
Common stock, $0.01 par value per share
|
| |
$115,000,000
|
| |
$12,546.50
|
(1)
|
Estimated solely for purposes of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended.
|
(2)
|
Includes the aggregate offering price of additional shares that the underwriters have the option to purchase.
|
•
|
We were recently formed and have limited operating history, and may not be able to successfully operate our business, integrate new assets and/or manage our growth or to generate sufficient revenue to make or sustain distributions to our stockholders.
|
•
|
Competition for the capital that we provide may reduce the return of our loans, which could adversely affect our operating results and financial condition.
|
•
|
We are externally managed by AFC Management, LLC (our “Manager”) and our growth and success depends on our Manager, its key personnel and investment professionals, and our Manager’s ability to make loans on favorable terms that satisfy our investment strategy and otherwise generate attractive risk-adjusted returns; thus, if our Manager overestimates the yields or incorrectly prices the risks of our loans or if there are any adverse changes in our relationship with our Manager, we may experience losses.
|
•
|
We provide loans to established companies operating in the cannabis industry which involves significant risks, including the risk to our business of strict enforcement against our borrowers of the federal illegality of cannabis, and such loans lack liquidity, and we could lose all or part of any of our loans.
|
•
|
Our ability to grow our business depends on state laws pertaining to the cannabis industry. New laws that are adverse to our borrowers may be enacted, and current favorable state or national laws or enforcement guidelines relating to cultivation, production and distribution of cannabis may be modified or eliminated in the future, which would impede our ability to grow our business under our current business plan and could materially adversely affect our business.
|
•
|
As a debt investor, we are often not in a position to exert influence on borrowers, and the stockholders and management of such companies may make decisions that could decrease the value of loans made to such borrower.
|
•
|
Our growth depends on external sources of capital, which may not be available on favorable terms or at all.
|
•
|
Interest rate fluctuations could increase our financing costs, which could lead to a significant decrease in our results of operations, cash flows and the market value of our loans.
|
•
|
There are various conflicts of interest in our relationship with our Manager, including conflicts created by our Manager’s compensation arrangements with us, which could result in decisions that are not in the best interests of our stockholders.
|
•
|
Maintenance of our exemption from registration under the Investment Company Act of 1940, as amended (the “Investment Company Act”), may impose significant limits on our operations. Your investment return in our Company may be reduced if we are required to register as an investment company under the Investment Company Act.
|
•
|
We may be deemed to be Closely Held (as defined below), which, subject to our ability to redeem certain shares of our capital stock, would result in us failing to qualify as a REIT and, subject to any required approvals by our Board and our stockholders, would trigger our dissolution and windup process.
|
•
|
Failure to qualify as a REIT for U.S. federal income tax purposes would cause us to be taxed as a regular corporation, which would substantially reduce funds available for distributions to our stockholders.
|
•
|
We may incur significant debt, and our governing documents and current credit facility contain no limit on the amount of debt we may incur.
|
•
|
We may in the future pay distributions from sources other than our cash flow from operations, including borrowings, offering proceeds or the sale of assets, which means we will have less funds available for investments or less income-producing assets and your overall return may be reduced.
|
•
|
There is currently no public market for our common stock and the value of our common stock may be volatile and could decline substantially.
|
|
| |
Price to Public
|
| |
Underwriting Discounts
and Commissions(1)(2)
|
| |
Proceeds to
Company(2)
|
Per Share
|
| |
$
|
| |
$
|
| |
$
|
Total
|
| |
$
|
| |
$
|
| |
$
|
(1)
|
See “Underwriting” for additional disclosure regarding of the compensation payable to the underwriters.
|
(2)
|
Reflects that no underwriting discounts or commissions will be applied to the Reserved Shares.
|
JMP Securities
|
Ladenburg Thalmann
|
Seaport Global Securities
|
|
| |
Page
|
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| |
Origination
|
| |
Underwriting
|
| |
Investment Committee
|
| |
Legal Documentation and
Post-Closing
|
||||||||||||
•
|
| |
Direct origination platform works to create enhanced yields by originating and structuring loans, as well as putting in enhanced controls
|
| |
•
|
| |
Disciplined underwriting process leads to a highly selective approach
|
| |
•
|
| |
Focused on managing credit risk through comprehensive investment review process
|
| |
•
|
| |
Investment team works alongside external counsel to negotiate credit agreements and collateral liens
|
•
|
| |
Platform drives increased deal flow, which provides for improved loan selectivity
|
| |
•
|
| |
Potential loans are screened based on four key criteria: company profile, state dynamics, regulatory matters and real estate asset considerations
|
| |
•
|
| |
The Investment Committee must approve each loan before commitment papers are issued
|
| |
•
|
| |
Emphasis is placed on financial covenants and limitations on actions that may be adverse to lenders
|
•
|
| |
Allows for specific portfolio construction and a focus on higher quality companies
|
| |
•
|
| |
Other tools that we frequently use to verify data include, but are not limited to: appraisals, quality of earnings, environmental reports, site visits, comparable company analyses and background checks
|
| |
•
|
| |
Members of the Investment Committee currently include: Leonard M. Tannenbaum, Jonathan Kalikow and Robyn Tannenbaum. It is intended that the Investment Committee will be expanded to five members consisting of the three current members and our to-be named Managing Director, Portfolio Management and General Counsel
|
| |
•
|
| |
Portfolio is proactively managed to monitor ongoing performance, in some instances, through seats on borrowers’ boards of directors or board observer rights
|
•
|
| |
As of December 26, 2020, 34 active loans in pipeline at various stages in the diligence process
|
| |
•
|
| |
As of December 26, 2020, we had passed on 185 of 229 sourced loans due to, among other reasons, lack of collateral, lack of cash flow, stage of company, no previous experience and state dynamics
|
| |
|
| |
|
| |
|
| |
|
(1)
|
All loans originated prior to July 31, 2020 were purchased from an affiliated entity at fair value plus accrued interest on July 31, 2020.
|
(2)
|
Loans originated before July 31, 2020 were acquired by us, net of unaccreted OID, which we accrete to income over the remaining term of the loan.
|
(3)
|
Assumes no prepayment penalties or early payoffs.
|
(4)
|
Loan to Subsidiary of Public Company C includes a $3.0 million initial funding of a $15.0 million aggregate loan commitment, which has interest that includes 3.0% PIK interest. The amortization of the loan exceeds PIK interest. The loan also includes two early advances totaling $9.0 million against the $15.0 million aggregate loan commitment, with a 19.0% interest rate. Statistics shown are for the $15.0 million loan commitment, except the weighted average interest rate, which is based on the weighted average interest rate as of December 26, 2020.
|
(5)
|
YTM IRR for Public Company A, subsidiary of Public Company C, Private Company A and Private Company D is enhanced by purchase discounts attributed to the fair value of equity warrants that were separated from the loans prior to our acquisition of such loans. The purchase discounts accrete to income over the respective remaining terms of such loans.
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
Real Estate
|
| |
|
|||||||||
Borrower
|
| |
Date
|
| |
Our
Total
Commitment
|
| |
Percentage
of
Total
Portfolio
|
| |
Total
Funded
Debt
Issuance
|
| |
Our
Percentage
of the
Total Loan
|
| |
Estimated
Real
Estate
Value(1)
|
| |
Real Estate
Collateral
Coverage
|
| |
Implied Real
Estate
Collateral
|
| |
Our
Real
Estate
Collateral
Coverage
|
| |
|
Public Co. A - Real Estate Loan(2)
|
| |
7/3/2019
|
| |
$2,940,000
|
| |
2.6%
|
| |
$30,000,000
|
| |
9.8%
|
| |
$107,000,000
|
| |
3.57x
|
| |
$10,486,000
|
| |
3.57x
|
| ||
Public Co. A - Equipment Loan
|
| |
8/5/2019
|
| |
$4,000,000
|
| |
3.5%
|
| |
$20,000,000
|
| |
20.0%
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| ||
Public Co. B(3)
|
| |
1/31/2020
|
| |
$5,000,000
|
| |
4.4%
|
| |
$20,000,000
|
| |
25.0%
|
| |
$53,100,000
|
| |
2.66x
|
| |
$13,275,000
|
| |
2.66x
|
| ||
Subsidiary of Public Co. C(4)
|
| |
2/12/2020
|
| |
$15,000,000
|
| |
13.3%
|
| |
$15,000,000
|
| |
100.0%
|
| |
$31,178,600
|
| |
2.08x
|
| |
$31,178,600
|
| |
2.08x
|
| ||
Private Co. A(5)
|
| |
5/8/2020
|
| |
$34,000,000
|
| |
30.1%
|
| |
$42,500,000
|
| |
80.0%
|
| |
$51,384,281
|
| |
1.21x
|
| |
$41,107,425
|
| |
1.21x
|
| ||
Private Co. B(6)
|
| |
9/10/2020
|
| |
$8,000,000
|
| |
7.1%
|
| |
$8,000,000
|
| |
100.0%
|
| |
$14,556,107
|
| |
1.82x
|
| |
$14,556,107
|
| |
1.82x
|
| ||
Private Co. C(7)
|
| |
11/5/2020
|
| |
$22,000,000
|
| |
19.5%
|
| |
$22,000,000
|
| |
100.0%
|
| |
$23,733,032
|
| |
1.08x
|
| |
$23,733,032
|
| |
1.08x
|
| ||
Subsidiary of Public Co. D(8)
|
| |
12/18/2020
|
| |
$10,000,000
|
| |
8.9%
|
| |
$120,000,000
|
| |
8.3%
|
| |
$26,058,332
|
| |
0.22x
|
| |
$2,171,528
|
| |
0.22x
|
| ||
Private Co. D(9)
|
| |
12/23/2020
|
| |
$12,000,000
|
| |
10.6%
|
| |
$12,000,000
|
| |
100.0%
|
| |
$7,500,000
|
| |
0.63x
|
| |
$7,500,000
|
| |
0.63x
|
| ||
|
| |
|
| |
$112,940,000
|
| |
100.0%
|
| |
$289,500,000
|
| |
39.0%
|
| |
$314,510,351
|
| |
1.09x
|
| |
$144,007,691
|
| |
1.28x
|
| ||
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
(1)
|
To the extent the applicable loan is intended to fund any acquisitions and/or construction, the applicable figure includes expected total basis on such future construction and/or acquisitions plus appraised value.
|
(2)
|
Public Company A real estate is based on cost basis.
|
(3)
|
Public Company B real estate is based on cost basis.
|
(4)
|
Subsidiary of Public Company C real estate is based on an existing cultivation property and the completed and stabilized value of a to-be-built facility. The anticipated completion date for the to-be-built facility is November 2021.
|
(5)
|
Private Company A real estate is based on the cost basis of various facilities constituting real estate collateral, plus anticipated capital expenditures for one facility that is being converted for cannabis cultivation purposes. The conversion is anticipated to be completed in February 2021.
|
(6)
|
Private Company B real estate is based on the expected total cost basis of a to-be-built facility, as completed. The anticipated completion date for the to-be-built facility is July 2021.
|
(7)
|
Private Company C real estate is based on the costs basis of two facilities, including the capital expenditures for one facility that is being converted for cannabis cultivation purposes. The construction of the to-be-converted facility is divided into six phases. The first phase was completed in December 2020, and the anticipated completion date for the remaining phases of construction is November 2021.
|
(8)
|
Subsidiary of Public Company D real estate based on total cost basis.
|
(9)
|
Private Company D real estate is based on appraised value.
|
Type
|
| |
Description
|
| |
Payment
|
Base Management Fees
|
| |
An amount equal to 0.375% of our Equity (as defined below), determined as of the last day of each such quarter. The Base Management Fees are reduced by 50% of the aggregate amount of any other fees earned and paid to our Manager during such quarter resulting from the investment advisory services and general management services rendered by it under our Management Agreement, including any syndication, structuring, diligence, monitoring or agency fees relating to our loans, but excluding the Incentive Compensation. Under no circumstances will the Base Management Fee be less than zero. Our Equity, for purposes of calculating the Base Management Fees, could be greater than or less than the amount of stockholders’ equity shown on our financial statements. The Base Management Fees are payable independent of the performance of our loan portfolio.
For additional information, see “Management Compensation—Base Management Fees.”
|
| |
Quarterly in arrears in cash.
|
|
| |
|
| |
|
Type
|
| |
Description
|
| |
Payment
|
Incentive Compensation
|
| |
An amount with respect to each calendar quarter (or portion thereof that our Management Agreement is in effect) based upon our achievement of targeted levels of Core Earnings. No Incentive Compensation is payable with respect to any fiscal quarter unless our Core Earnings for such quarter exceed the amount equal to the product of (i) 2% and (ii) Adjusted Capital (as defined below) as of the last day of the immediately preceding fiscal quarter (such amount, the “Hurdle Amount”). The Incentive Compensation for any fiscal quarter will otherwise be calculated as the sum of (i) the product of (A) 50% and (B) the amount of our Core Earnings for such quarter, if any, that exceeds the Hurdle Amount, but is less than or equal to 166-2/3% of the Hurdle Amount and (ii) the product of (A) 20% and (B) the amount of our Core Earnings for such quarter, if any, that exceeds 166-2/3% of the Hurdle Amount. Such compensation is subject to Clawback Obligations (as defined below), if any.
For additional information, see “Management Compensation—Incentive Compensation” and “Management Compensation—Incentive Compensation—Incentive Compensation Clawback.”
|
| |
Quarterly in arrears in cash.
|
Expense Reimbursement
|
| |
We pay all of our costs and expenses and reimburse our Manager or its affiliates for expenses of our Manager and its affiliates paid or incurred on our behalf, excepting only those expenses that are specifically the responsibility of our Manager pursuant to our Management Agreement. Pursuant to our Management Agreement, we reimburse our Manager or its affiliates, as applicable, for our allocable share of the compensation, including annual base salary, bonus, any related withholding taxes and employee benefits, paid to (i) our Manager’s personnel serving as our Chief Executive Officer (except when the Chief Executive Officer serves as a member of the Investment Committee), General Counsel, Chief Compliance Officer, Chief Financial Officer, Chief Marketing Officer, and Managing Director of Origination, Investor Relations and Marketing, as applicable, based on the percentage of his or her time spent managing our affairs and (ii) other corporate finance, tax, accounting, internal audit, legal, risk management, operations, compliance and other non-investment personnel of the Manager and its affiliates who spend all or a portion of their time managing our affairs; provided that we are not obligated to reimburse our Manager or its affiliates, as applicable, for any compensation paid to Mr. Tannenbaum, Mr. Kalikow and Mrs. Tannenbaum. Our share of such costs are based upon the percentage of time devoted by such personnel of our Manager or its affiliates to our affairs.
For additional information, see “Management Compensation—Expense Reimbursement.”
|
| |
Monthly in cash.
|
|
| |
|
| |
|
Type
|
| |
Description
|
| |
Payment
|
Termination Fee
|
| |
Equal to three times the sum of (i) the average annual Base Management Fee and (ii) the average annual Incentive Compensation, in each case, earned by our Manager during the 12-month period immediately preceding the most recently completed fiscal quarter prior to the date of termination. Such fee shall be payable upon termination of our Management Agreement in the event that (i) we decline to renew our Management Agreement, without cause, upon 180 days prior written notice and the affirmative vote of at least two-thirds of our independent directors that there has been unsatisfactory performance by our Manager that is materially detrimental to us taken as a whole, or (ii) our Management Agreement is terminated by our Manager (effective upon 60 days’ prior written notice) based upon our default in the performance or observance of any material term, condition or covenant contained in our Management Agreement and such default continuing for a period of 30 days after written notice thereof specifying such default and requesting that the same be remedied in such 30-day period.
For additional information, see “Management Compensation—Termination Fee.”
|
| |
Upon specified termination in cash.
|
•
|
Targeting loans for origination and investment that typically have the following characteristics:
|
○
|
principal balance greater than $10 million;
|
○
|
real estate collateral coverage of at least one times the principal balance;
|
○
|
secured by commercial real estate properties, including cannabis cultivation facilities, processing facilities, and dispensaries; and
|
○
|
well-capitalized sponsors with substantial experience in particular real estate sectors and geographic markets.
|
•
|
Diversifying our financing sources with increased access to equity and debt capital, which may provide us with a lower overall cost of funding and the ability to hold larger loan sizes, among other things.
|
|
| |
For the period from July 31, 2020
(date of commencement of
operations) to September 30, 2020
|
Net Income
|
| |
$2,106,250
|
Adjustments to net income
|
| |
|
Non-cash equity compensation expense
|
| |
—
|
Incentive Compensation to Manager(1)
|
| |
—
|
Depreciation and amortization
|
| |
—
|
Unrealized (gain), losses or other non-cash items
|
| |
(1,563,800)
|
One-time events pursuant to changes in GAAP and certain non-cash charges
|
| |
—
|
Core Earnings
|
| |
$542,450
|
Adjustments to Core Earnings
|
| |
|
Certain organizational expenses
|
| |
616,190
|
Adjusted Core Earnings
|
| |
$1,158,640
|
Basic weighted average shares of common stock outstanding
(in shares, on a post-split basis)
|
| |
5,376,411
|
Adjusted Core Earnings per Weighted Average Share (on a post-split basis)
|
| |
$0.22
|
(1)
|
Our Manager has agreed to waive the Incentive Compensation for the period from July 31, 2020 (date of commencement of operations) through December 31, 2020.
|
•
|
We were recently formed and have limited operating history, and may not be able to successfully operate our business, integrate new assets and/or manage our growth or to generate sufficient revenue to make or sustain distributions to our stockholders.
|
•
|
Competition for the capital that we provide may reduce the return of our loans, which could adversely affect our operating results and financial condition.
|
•
|
We are externally managed by our Manager and our growth and success depends on our Manager, its key personnel and investment professionals, and our Manager’s ability to make loans on favorable terms that satisfy our investment strategy and otherwise generate attractive risk-adjusted returns; thus, if our Manager overestimates the yields or incorrectly prices the risks of our loans or if there are any adverse changes in our relationship with our Manager, we may experience losses.
|
•
|
We provide loans to established companies operating in the cannabis industry which involves significant risks, the risk to our business of strict enforcement against our borrowers of the federal illegality of cannabis, and such loans lack liquidity, and we could lose all or part of any of our loans.
|
•
|
Our ability to grow our business depends on state laws pertaining to the cannabis industry. New laws that are adverse to our borrowers may be enacted, and current favorable state or national laws or enforcement guidelines relating to cultivation, production and distribution of cannabis may be modified or eliminated in the future, which would impede our ability to grow our business under our current business plan and could materially adversely affect our business.
|
•
|
As a debt investor, we are often not in a position to exert influence on borrowers, and the stockholders and management of such companies may make decisions that could decrease the value of loans to such borrower.
|
•
|
Our growth depends on external sources of capital, which may not be available on favorable terms or at all.
|
•
|
Interest rate fluctuations could increase our financing costs, which could lead to a significant decrease in our results of operations, cash flows and the market value of our loans.
|
•
|
There are various conflicts of interest in our relationship with our Manager, including conflicts created by our Manager’s compensation arrangements with us, which could result in decisions that are not in the best interests of our stockholders.
|
•
|
Maintenance of our exemption from registration under the Investment Company Act may impose significant limits on our operations. Your investment return in our Company may be reduced if we are required to register as an investment company under the Investment Company Act.
|
•
|
We may be deemed to be “closely held” within the meaning of Section 856(a)(6) (without regard to Section 856(h)(2)) of the Code (“Closely Held”), subject to our ability to redeem certain shares of our capital stock, would result in us failing to qualify as a REIT and, subject to any required approvals by our Board and our stockholders, would trigger our dissolution and windup process.
|
•
|
Failure to qualify as a REIT for U.S. federal income tax purposes would cause us to be taxed as a regular corporation, which would substantially reduce funds available for distributions to our stockholders.
|
•
|
We may incur significant debt, and our governing documents and current credit facility contain no limit on the amount of debt we may incur.
|
•
|
We may in the future pay distributions from sources other than our cash flow from operations, including borrowings, offering proceeds or the sale of assets, which means we will have less funds available for investments or less income-producing assets and your overall return may be reduced.
|
•
|
There is currently no public market for our common stock and the value of our common stock may be volatile and could decline substantially.
|
•
|
an exemption from the auditor attestation requirements with respect to internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”);
|
•
|
exemption from say-on-pay, say-on-frequency and say-on-golden parachute voting requirements;
|
•
|
reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements; and
|
•
|
an extended transition period to defer compliance with new or revised accounting standards until such date that a private company is otherwise required to comply with such new or revised accounting standards.
|
(i)
|
67,586 shares of common stock (on a pre-split basis, or 473,102 shares, on a post-split basis) expected to be reserved for future grant or issuance under our 2020 Stock Incentive Plan (after giving effect to the issuance of options referenced in clause (iii) below), which shares will automatically increase each year starting on , , as more fully described in “Management—2020 Stock Incentive Plan”;
|
(ii)
|
132,414 shares of common stock (on a pre-split basis, or 926,898 shares, on a post-split basis) issuable upon exercise of options outstanding as of December 26, 2020, having a weighted-average exercise price of approximately $103.59 per share; and
|
(iii)
|
up to 100,000 shares of common stock (on a pre-split basis, or 700,000 shares on a post-split basis) issuable upon exercise of options authorized as of December 26, 2020, to be issued immediately prior to the consummation of this offering at an exercise price equal to the per share price to the public in this offering on a post-split basis.
|
(i)
|
882,770 shares of common stock (on a pre-split basis, or 6,179,392 shares, on a post-split basis) outstanding as of December 26, 2020;
|
(ii)
|
the underwriters will not exercise their over-allotment option in this offering;
|
(iii)
|
no issuance or exercise of stock options on or after December 26, 2020;
|
(iv)
|
no purchases of Reserved Shares by existing stockholders or their affiliates pursuant to the indications of interest, described above or pursuant to the directed share program;
|
(v)
|
the seven-for-one stock split of our common stock, which will occur immediately prior to consummation of this offering; and
|
(vi)
|
the effectiveness of our Articles of Amendment and Restatement, which will occur immediately prior to the completion of this offering.
|
|
| |
As of and for the period from July 31,
2020 (date of commencement of
operations) to September 30, 2020
|
Statement of Operations Data:
|
| |
|
Revenue
|
| |
|
Interest Income
|
| |
$1,594,769
|
Total revenue
|
| |
1,594,769
|
|
| |
|
Expenses
|
| |
|
Management fees, net (less rebate of $84,167)
|
| |
142,067
|
General and administrative expense
|
| |
204,262
|
Organizational expense
|
| |
616,190
|
Professional fees
|
| |
89,800
|
Total expenses
|
| |
1,052,319
|
|
| |
|
Net realized and change in unrealized gains / (losses) on loans at fair value
|
| |
|
Change in unrealized gains / (losses) on loans at fair value, net
|
| |
1,563,800
|
Total net realized and change in unrealized gains / (losses) on loans at fair value
|
| |
1,563,800
|
|
| |
|
Net Income / (loss) before income taxes
|
| |
2,106,250
|
Income tax expense
|
| |
—
|
Net Income / (loss)
|
| |
2,106,250
|
|
| |
|
Earnings per common share:
|
| |
|
Basic earnings per common share (in dollars per share, on a post-split basis)
|
| |
$0.39
|
|
| |
|
Weighted average number of common shares outstanding:
|
| |
|
Basic weighted average shares of common stock outstanding (in shares, on a post-split basis)(1)
|
| |
5,376,411
|
|
| |
|
Balance Sheet Data:
|
| |
|
Total assets(1)
|
| |
$82,717,823
|
Total liabilities
|
| |
$1,862,641
|
Total stockholders’ equity(1)
|
| |
$80,855,182
|
|
| |
|
Other Financial Data:
|
| |
|
Core Earnings(1)(2)
|
| |
$542,450
|
Adjusted Core Earnings(1)(2)
|
| |
$1,158,640
|
Adjusted Core Earnings per weighted average share of common stock (on a post-split basis)(1)(2)
|
| |
$0.22
|
(1)
|
Does not give effect to the Additional Closing or the Series A Offering, the changes to our loan portfolio, the sale of Assigned Rights or the dividends to our stockholders subsequent to September 30, 2020. See “—Recent Developments” for additional information.
|
(2)
|
We use Core Earnings and Adjusted Core Earnings to evaluate our performance excluding the effects of certain transactions and non-GAAP adjustments we believe are not necessarily indicative of our current loan activity and operations. Each of Core Earnings and Adjusted Core Earnings is a measure that is not prepared in accordance with GAAP. We define Core Earnings as, for a given period, the net income (loss) computed in accordance with GAAP, excluding (i) non-cash equity compensation expense, (ii) Incentive Compensation, (iii) depreciation and amortization, (iv) any unrealized gains, losses or other non-cash items recorded in net income (loss) for the period, regardless of whether such items are included in other comprehensive income or loss, or in net income (loss); provided that Core Earnings does not exclude, in the case of investments with a deferred interest feature (such as OID, debt instruments with PIK interest and zero coupon securities), accrued income that we have not yet received in cash, and (v) one-time events pursuant to changes in GAAP and certain non-cash charges, in each case after discussions between our Manager and our independent directors and after approval by a majority of such independent directors. We define Adjusted Core Earnings, for a specified period, as Core Earnings excluding certain non-recurring organizational expenses (such as one-time expenses related to our formation and start-up). We believe providing Core Earnings and Adjusted Core Earnings on a supplemental basis to our net income as determined in accordance with GAAP is helpful to stockholders in assessing the overall performance of our business. Core Earnings and Adjusted Core Earnings should not be considered as substitutes for GAAP net income. We caution readers that our methodology for calculating Core Earnings and Adjusted Core Earnings may differ from the methodologies employed by other REITs to calculate the same or similar supplemental performance measures, and as a result, our reported Core Earnings and Adjusted Core Earnings may not be comparable to similar measures presented by other REITs. We also use Core Earnings to determine the fees we pay our Manager. For information on the fees we pay our Manager, see “Management Compensation.” The following table provides a reconciliation of GAAP net income to Core Earnings and Adjusted Core Earnings (in thousands, except per share data):
|
|
| |
For the period from July 31, 2020
(date of commencement of
operations) to September 30, 2020
|
Net Income
|
| |
$2,106,250
|
Adjustments to net income
|
| |
|
Non-cash equity compensation expense
|
| |
—
|
Incentive Compensation to Manager(1)
|
| |
—
|
Depreciation and amortization
|
| |
—
|
Unrealized (gains), losses or other non-cash items
|
| |
(1,563,800)
|
One-time events pursuant to changes in GAAP and certain non-cash charges
|
| |
—
|
Core Earnings
|
| |
$542,450
|
Adjustments to Core Earnings
|
| |
|
Certain organizational expenses
|
| |
616,190
|
Adjusted Core Earnings
|
| |
$ 1,158,640
|
Basic weighted average shares of common stock outstanding (in shares, on a
post-split basis)
|
| |
5,376,411
|
Adjusted Core Earnings per Weighted Average Share (on a post-split basis)
|
| |
$0.22
|
(1)
|
Our Manager has agreed to waive the Incentive Compensation for the period from July 31, 2020 (date of commencement of operations) through December 31, 2020.
|
•
|
the development and growth of applicable state cannabis markets;
|
•
|
the responsibility of complying with multiple and likely conflicting state and federal laws, including with respect to retail sale, distribution, cultivation and manufacturing of cannabis, licensing, banking, and insurance;
|
•
|
unexpected changes in regulatory requirements and other laws;
|
•
|
difficulties and costs of managing operations in certain locations;
|
•
|
potentially adverse tax consequences;
|
•
|
the impact of national, regional or state specific business cycles and economic instability; and
|
•
|
access to capital may be more restricted, or unavailable on favorable terms or at all in certain locations.
|
•
|
these companies may have limited financial resources and may be unable to meet their obligations, which may be accompanied by a deterioration in the value of any collateral securing our loan and a reduction in the likelihood of us realizing a return on our loan;
|
•
|
they typically have shorter operating histories, narrower product lines and smaller market shares than larger and more established businesses, which tend to render them more vulnerable to competitors’ actions and market conditions (including conditions in the cannabis industry), as well as general economic downturns;
|
•
|
they typically depend on the management talents and efforts of a small group of persons; therefore, the death, disability, resignation or termination of one or more of these persons could have a material adverse effect on such borrower and, in turn, on us;
|
•
|
there is generally less public information about these companies. Unless publicly traded, these companies and their financial information are generally not subject to the regulations that govern public companies, and we may be unable to uncover all material information about these companies, which may prevent us from making a fully informed lending decision and cause us to lose money on our loans;
|
•
|
they generally have less predictable operating results and may require substantial additional capital to support their operations, finance expansion or maintain their competitive position;
|
•
|
we, our executive officers and directors and our Manager may, in the ordinary course of business, be named as defendants in litigation arising from our loans to such borrowers and may, as a result, incur significant costs and expenses in connection with such litigation;
|
•
|
changes in laws and regulations, as well as their interpretations, may have a disproportionate adverse effect on their business, financial structure or prospects compared to those of larger and more established companies; and
|
•
|
they may have difficulty accessing capital from other providers on favorable terms or at all.
|
•
|
a complete or partial closure of, or other operational issues at, one or more of our borrowers’ locations resulting from government or such company’s actions;
|
•
|
the temporary inability of consumers and patients to purchase our borrowers’ cannabis products due to a number of factors, including, but not limited to, illness, dispensary closures or limitations on operations, quarantine, financial hardship, and “stay at home” orders;
|
•
|
difficulty accessing equity and debt capital on attractive terms, or at all, and a severe disruption and instability in the global financial markets or deteriorations in credit and financing conditions may affect our access to capital necessary to fund business operations and our borrowers’ ability to fund their business operations and meet their obligations to us;
|
•
|
workforce disruptions for our borrowers, as a result of infections, quarantines, “stay at home” orders or other factors, could result in a material reduction in our borrowers’ cannabis cultivation, manufacturing, distribution and/or sales capacity;
|
•
|
because of the federal regulatory uncertainty relating to the regulated cannabis industry, our borrowers have not been, and in the future likely will not be eligible, for financial relief available to other businesses;
|
•
|
restrictions on public events for the regulated cannabis industry limit the opportunity for our borrowers to market and sell their products and promote their brands;
|
•
|
delays in construction at the properties of our borrowers may adversely impact their ability to commence operations and generate revenues from projects;
|
•
|
a general decline in business activity in the regulated cannabis industry would adversely affect our ability to grow our portfolio of loans to cannabis companies; and
|
•
|
the potential negative impact on the health of our personnel, particularly if a significant number of them are impacted, would result in a deterioration in our ability to ensure business continuity during a disruption.
|
•
|
general economic or market conditions;
|
•
|
the market’s view of the quality of our assets;
|
•
|
the market’s perception of our growth potential;
|
•
|
the current regulatory environment with respect to our business; and
|
•
|
our current and potential future earnings and cash distributions.
|
•
|
our cash flow from operations may be insufficient to make required payments of principal of and interest on the debt we incur or we may fail to comply with all of the other covenants contained in such debt, which is likely to result in (i) acceleration of such debt (and any other debt containing a cross-default or cross-acceleration provision) that we may be unable to repay from internal funds or to refinance on favorable terms, or at all, (ii) our inability to borrow unused amounts under our financing arrangements, even if we are current in payments on borrowings under those arrangements, and/or (iii) the loss of some or all of our assets to foreclosure or sale;
|
•
|
we may be unable to borrow additional funds as needed or on favorable terms, or at all;
|
•
|
to the extent we borrow debt that bears interest at variable rates, increases in interest rates could materially increase our interest expense;
|
•
|
our default under any loan with cross-default provisions could result in a default on other indebtedness;
|
•
|
incurring debt may increase our vulnerability to adverse economic and industry conditions with no assurance that loan yields will increase with higher financing costs;
|
•
|
we may be required to dedicate a substantial portion of our cash flow from operations to payments on the debt we may incur, thereby reducing funds available for operations, future business opportunities, stockholder distributions, including distributions currently contemplated or necessary to satisfy the requirements for REIT qualification, or other purposes; and
|
•
|
we are not able to refinance debt that matures prior to the loan it was used to finance on favorable terms, or at all.
|
•
|
80% of the votes entitled to be cast by holders of the then-outstanding shares of voting stock of such corporation; and
|
•
|
two-thirds of the votes entitled to be cast by holders of voting stock of such corporation, other than shares held by the interested stockholder with whom or with whose affiliate the business combination is to be effected, or held by an affiliate or associate of the interested stockholder.
|
•
|
we would not be allowed a deduction for distributions paid to stockholders in computing our taxable income and would be subject to U.S. federal income tax at regular corporate rates;
|
•
|
we could be subject to increased state and local taxes; and
|
•
|
unless we are entitled to relief under statutory provisions, we would not be able to re-elect to be taxed as a REIT for four taxable years following the year in which we were disqualified.
|
•
|
our actual or projected operating results, financial condition, cash flows and liquidity or changes in business strategy or prospects;
|
•
|
changes in governmental policies, regulations or laws;
|
•
|
loss of a major funding source or inability to obtain new favorable funding sources in the future;
|
•
|
equity issuances by us, or share resales by our stockholders, or the perception that such issuances or resales may occur;
|
•
|
actual, anticipated or perceived accounting or internal control problems;
|
•
|
publication of research reports about us, the real estate industry or the cannabis industry;
|
•
|
our value of the properties securing our loans;
|
•
|
changes in market valuations of similar companies;
|
•
|
adverse market reaction to any increased indebtedness we may incur in the future;
|
•
|
additions to or departures of the executive officers or key personnel supporting or assisting us from our Manager or its affiliates, including our Manager’s investment professionals;
|
•
|
speculation in the press or investment community about us or other similar companies;
|
•
|
our failure to meet, or the lowering of, our earnings estimates or those of any securities analysts;
|
•
|
increases in market interest rates, which may lead investors to demand a higher distribution yield for our common stock (if we have begun to make distributions to our stockholders) and which could cause the cost of our interest expenses on our debt to increase;
|
•
|
failure to qualify or maintain our qualification as a REIT or exclusion from the Investment Company Act;
|
•
|
price and volume fluctuations in the stock market generally; and
|
•
|
general market and economic conditions, including the state of the credit and capital markets.
|
•
|
use of proceeds of this offering;
|
•
|
our business and investment strategy;
|
•
|
the impact of COVID-19 on our business and the global economy;
|
•
|
the ability of our Manager to locate suitable loan opportunities for us, monitor and actively manage our loan portfolio and implement our investment strategy;
|
•
|
allocation of loan opportunities to us by our Manager;
|
•
|
our projected operating results;
|
•
|
actions and initiatives of the U.S. or state governments and changes to government policies and the execution and impact of these actions, initiatives and policies, including the fact that cannabis remains illegal under federal law;
|
•
|
the estimated growth in and evolving market dynamics of the cannabis market;
|
•
|
the demand for cannabis cultivation and processing facilities;
|
•
|
shifts in public opinion regarding cannabis;
|
•
|
the state of the U.S. economy generally or in specific geographic regions;
|
•
|
economic trends and economic recoveries;
|
•
|
the amount and timing of our cash flows, if any, from our loans;
|
•
|
our ability to obtain and maintain financing arrangements;
|
•
|
our expected leverage;
|
•
|
changes in the value of our loans;
|
•
|
our expected portfolio of loans;
|
•
|
our expected investment and underwriting process;
|
•
|
rates of default or decreased recovery rates on our loans;
|
•
|
the degree to which any interest rate or other hedging strategies may or may not protect us from interest rate volatility;
|
•
|
changes in interest rates and impacts of such changes on our results of operations, cash flows and the market value of our loans;
|
•
|
interest rate mismatches between our loans and our borrowings used to fund such loans;
|
•
|
the departure of any of the executive officers or key personnel supporting and assisting us from our Manager or its affiliates;
|
•
|
impact of and changes in governmental regulations, tax law and rates, accounting guidance and similar matters;
|
•
|
our ability to maintain our exclusion or exemption from registration under the Investment Company Act;
|
•
|
our ability to qualify and maintain our qualification as a REIT for U.S. federal income tax purposes;
|
•
|
estimates relating to our ability to make distributions to our stockholders in the future;
|
•
|
our understanding of our competition; and
|
•
|
market trends in our industry, interest rates, real estate values, the securities markets or the general economy.
|
(1)
|
The above table provides a summary of various unfunded commitments and non-binding term sheets relating to current financing arrangements we intend to fund utilizing proceeds from this offering, subject to the closing of the loans subject to term sheets. Other than the unfunded commitments to existing borrowers, Public Company C, Private Company A, Private Company B and Private Company C, representing an aggregate principal amount of approximately $19.8 million, we have not entered into binding definitive commitments relating to these loans. As of December 26, 2020, we have executed non-binding term sheets in connection with three loans representing approximately $62.7 million of anticipated loan commitments and have each entered into a period of exclusivity (ranging from 45 to 60 days) with respect to such proposed loans with two of the three prospective borrowers paying us expense deposits to cover the direct costs of our due diligence and underwriting process. We are currently completing our underwriting process and negotiating definitive loan documents for each of these three potential loan investments. However, these three potential loans remain subject to satisfactory completion of our underwriting and due diligence processes, definitive documentation and final approval by the Investment Committee. As a result, no assurance can be given that any of these potential loans will close on the anticipated terms or at all. If these potential loans do not close, we intend to use the proceeds from this offering to originate and participate in other commercial loans to companies operating in the cannabis industry that are consistent with our investment strategy, which we would expect to have similar characteristics as the terms reflected in this table.
|
•
|
on an actual basis;
|
•
|
on a pro forma basis, giving effect to (i) the sale and issuance by us of shares of our common stock in connection with the Additional Closing for consideration of approximately $15.19 per share (on a post-split basis), after giving effect to the reallocation of organizational costs, (ii) the sale and issuance by us of shares of our Series A Preferred Stock in connection with the Series A Offering for consideration of $1,000 per share and (iii) the seven-for-one stock split of our common stock, which will occur immediately prior to consummation of this offering;
|
•
|
on a pro forma as adjusted basis, giving effect to (i) the sale and issuance by us of shares of our common stock in connection with the Additional Closing for consideration of approximately $15.19 per share (on a post-split basis), after giving effect to the reallocation of organizational costs, (ii) the sale and issuance by us of shares of our Series A Preferred Stock in connection with the Series A Offering for consideration of $1,000 per share, (iii) the seven-for-one stock split of our common stock, which will occur immediately prior to consummation of this offering, and (iv) the sale and issuance by us of shares of our common stock in this offering, based upon the assumed initial public offering price of $ per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us and giving effect to the use of proceeds described herein.
|
|
| |
As of September 30, 2020
|
||||||
|
| |
Actual
|
| |
Pro Forma
|
| |
Pro Forma as
Adjusted(1)
|
|
| |
(in dollars except share data)
|
||||||
Cash and cash equivalents
|
| |
$31,247,004
|
| |
$43,652,004
|
| |
|
Debt:
|
| |
|
| |
|
| |
|
Revolving Credit Facility
|
| |
—
|
| |
—
|
| |
|
Stockholders’ equity:
|
| |
|
| |
|
| |
|
Preferred stock, $0.01 par value per share: 10,000 shares authorized and no shares issued and outstanding (actual); 10,000 shares authorized and 125 shares of Series A Preferred Stock issued and outstanding (pro forma and pro forma as adjusted)
|
| |
—
|
| |
1
|
| |
|
Common stock: $0.01 par value per share: 15,000,000 shares authorized, 768,059 shares (on a pre-split basis) issued and outstanding (actual); 15,000,000 shares authorized, 6,179,392 shares issued and outstanding (pro forma); 15,000,000 shares authorized, shares issued and outstanding (pro forma as adjusted)
|
| |
7,681
|
| |
61,794
|
| |
|
Additional paid-in capital
|
| |
78,741,251
|
| |
91,092,136
|
| |
|
Accumulated earnings
|
| |
2,106,250
|
| |
2,106,250
|
| |
|
Total stockholders’ equity
|
| |
80,855,182
|
| |
93,260,182
|
| |
|
Total Capitalization
|
| |
80,855,182
|
| |
93,260,182
|
| |
|
(1)
|
Each $1.00 increase or decrease in the assumed initial public offering price of $ per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, would increase or decrease, as applicable, the amount of our pro forma as adjusted cash and cash equivalents and total stockholders’ equity by $ million, assuming that the number of
|
Assumed initial public offering price per share of our common stock
|
| |
|
| |
$
|
Historical net tangible book value per share of our common stock as of September 30, 2020 (on a post-split basis)
|
| |
$15.04
|
| |
|
Increase in net tangible book value per share of our common stock attributable to the pro forma transactions
|
| |
$0.05
|
| |
|
Increase in net tangible book value per share of our common stock attributable to this offering
|
| |
$
|
| |
|
Pro forma as adjusted net tangible book value per share of our common stock, as adjusted to give effect to the pro forma transactions and this offering
|
| |
|
| |
|
Dilution per share to new investors participating in this offering (1)
|
| |
|
| |
$
|
(1)
|
Dilution is determined by subtracting the pro forma as adjusted net tangible book value per share from the assumed initial public offering price paid by a new investor for a share of our common stock.
|
(1)
|
Number of shares in this table reflects the seven-for-one stock split of our common stock, which will occur immediately prior to consummation of this offering, but does not reflect the number of shares of common stock sold to investors in connection with the Additional Closing in November 2020. Number of actual shares purchased by existing common stockholders as of September 30, 2020 was 768,059 shares.
|
|
| |
As of and for the period from July 31,
2020 (date of commencement of
operations) to September 30, 2020
|
|
| |
(in dollars except share data)
|
Statement of Operations Data:
|
| |
|
Revenue
|
| |
|
Interest Income
|
| |
$1,594,769
|
Total revenue
|
| |
1,594,769
|
|
| |
|
Expenses
|
| |
|
Management fees, net (less rebate of $84,167)
|
| |
142,067
|
General and administrative expense
|
| |
204,262
|
Organizational expense
|
| |
616,190
|
Professional fees
|
| |
89,800
|
Total expenses
|
| |
1,052,319
|
|
| |
|
Net realized and change in unrealized gains / (losses) on loans at fair value
|
| |
|
Change in unrealized gains / (losses) on loans at fair value, net
|
| |
1,563,800
|
Total net realized and change in unrealized gains / (losses) on loans at fair value
|
| |
1,563,800
|
|
| |
|
Net Income / (loss) before income taxes
|
| |
2,106,250
|
Income tax expense
|
| |
—
|
Net Income / (loss)
|
| |
$2,106,250
|
|
| |
|
Earnings per common share:
|
| |
|
Basic earnings per common share (in dollars per share, on a post-split basis)
|
| |
$0.39
|
|
| |
|
Weighted average number of common shares outstanding:
|
| |
|
Basic weighted average shares of common stock outstanding (in shares, on a post-split basis)(1)
|
| |
5,376,411
|
|
| |
|
Balance Sheet Data:
|
| |
|
Assets
|
| |
|
Loans held at fair value (cost of $45,539,161 net)
|
| |
$47,102,961
|
Loan receivable at carrying value (less allowance of $0 at September 30, 2020)
|
| |
3,559,156
|
Cash and cash equivalents
|
| |
31,247,004
|
Interest receivable
|
| |
783,673
|
Prepaid expenses and other assets
|
| |
25,029
|
Total assets(1)
|
| |
$82,717,823
|
|
| |
As of and for the period from July 31,
2020 (date of commencement of
operations) to September 30, 2020
|
|
| |
(in dollars except share data)
|
|
| |
|
Liabilities
|
| |
|
Interest reserve
|
| |
$1,400,000
|
Accrued management fees, net
|
| |
142,067
|
Accrued direct administrative expenses
|
| |
202,534
|
Accounts payable and other liabilities
|
| |
118,040
|
Total liabilities
|
| |
1,862,641
|
|
| |
|
Stockholders’ Equity
|
| |
|
Preferred stock, par value $0.01 per share, 10,000 shares authorized at September 30, 2020 and no shares issued and outstanding at September 30, 2020
|
| |
—
|
Common stock, par value $0.01 per share, 15,000,000 shares authorized at September 30, 2020 and 5,376,411 shares (on a post-split basis) issued and outstanding at September 30, 2020
|
| |
53,764
|
Additional paid-in-capital
|
| |
78,741,251
|
Accumulated earnings / (deficit)
|
| |
2,106,250
|
Total stockholders’ equity(1)
|
| |
80,855,182
|
Total liabilities and stockholders’ equity
|
| |
$82,717,823
|
|
| |
|
Net cash provided by / (used in) operating activities
|
| |
$(56,428)
|
Net cash provided by / (used in) investing activities
|
| |
$(642,660)
|
Net cash provided by / (used in) financing activities
|
| |
$31,946,092
|
(1)
|
Does not give effect to the Additional Closing or the Series A Offering, the changes to our portfolio investments, the sale of Assigned Rights or the dividends to our stockholders subsequent to September 30, 2020. See “Prospectus Summary—Recent Developments” for additional information.
|
•
|
organizational and offering expenses;
|
•
|
quarterly valuation expenses;
|
•
|
fees payable to third parties relating to, or associated with, making loans and valuing loans (including third-party valuation firms);
|
•
|
fees and expenses associated with investor relations and marketing efforts (including attendance at investment conferences and similar events);
|
•
|
federal and state registration fees;
|
•
|
any exchange listing fees;
|
•
|
federal, state and local taxes;
|
•
|
independent directors’ fees and expenses;
|
•
|
brokerage commissions;
|
•
|
costs of proxy statements, stockholders’ reports and notices; and
|
•
|
costs of preparing government filings, including periodic and current reports with the SEC.
|
•
|
we manage our portfolio through an interactive process with our Manager and service our self-originated loans through our Manager’s servicer;
|
•
|
we invest in a mix of floating- and fixed-rate loans to mitigate the interest rate risk associated with the financing of our portfolio;
|
•
|
we actively employ portfolio-wide and asset-specific risk measurement and management processes in our daily operations, including utilizing our Manager’s risk management tools such as software and services licensed or purchased from third-parties and proprietary analytical methods developed by our Manager; and
|
•
|
we seek to manage credit risk through our due diligence process prior to origination or acquisition and through the use of non-recourse financing, when and where available and appropriate. In addition, with respect to any particular target investment, prior to origination or acquisition our Manager’s investment team evaluates, among other things, relative valuation, comparable company analysis, supply and demand trends, shape-of-yield curves, delinquency and default rates, recovery of various sectors and vintage of collateral.
|
|
| |
As of September 30, 2020
|
|||||||||
|
| |
Fair Value(2)
|
| |
Carrying
Value(1)
|
| |
Outstanding
Principal(1)
|
| |
Weighted
Average
Remaining Life
(Years)(3)
|
Senior Term Loan
|
| |
$47,102,961
|
| |
$45,539,161
|
| |
$48,660,311
|
| |
2.7
|
Total loans held at fair value
|
| |
$47,102,961
|
| |
$45,539,161
|
| |
$48,660,311
|
| |
2.7
|
(1)
|
The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted purchase discount, deferred loan fees and loan origination costs.
|
(2)
|
Refer to footnote 12 to our financial statements titled “Fair Value.”
|
(3)
|
Weighted average remaining life is calculated based on the fair value of the loans as of September 30, 2020.
|
|
| |
Principal
|
| |
Origination
Costs and
Loan Fees
|
| |
Fair Value
|
Loans
|
| |
$46,080,604
|
| |
$(2,974,054)
|
| |
$43,106,550
|
Change in unrealized gains / (losses) on loans at fair value, net
|
| |
—
|
| |
—
|
| |
1,563,800
|
Additional funding
|
| |
2,500,000
|
| |
(320,000)
|
| |
2,180,000
|
Accretion of original issue discount
|
| |
—
|
| |
172,904
|
| |
172,904
|
PIK Interest
|
| |
79,707
|
| |
—
|
| |
79,707
|
Total loans held at fair value
|
| |
$48,660,311
|
| |
$(3,121,150)
|
| |
$47,102,961
|
|
| |
Principal
|
| |
Origination
Costs and
Loan Fees
|
| |
Carrying
Value
|
Loan receivable
|
| |
$3,700,718
|
| |
$(4,428)
|
| |
$3,696,290
|
Principal repayment of loans
|
| |
(137,340)
|
| |
—
|
| |
(137,340)
|
Accretion of original issue discount
|
| |
—
|
| |
206
|
| |
206
|
Total loans receivable at carrying value
|
| |
$3,563,378
|
| |
$(4,222)
|
| |
$3,559,156
|
|
| |
For the period from July 31, 2020
(date of commencement of
operations) to September 30, 2020
|
Net Income
|
| |
$2,106,250
|
Adjustments to net income
|
| |
|
Non-cash equity compensation expense
|
| |
—
|
Incentive Compensation to Manager (1)
|
| |
—
|
Depreciation and amortization
|
| |
—
|
Unrealized (gain), losses or other non-cash items
|
| |
(1,563,800)
|
One-time events pursuant to changes in GAAP and certain non-cash charges
|
| |
—
|
Core Earnings
|
| |
$542,450
|
|
| |
|
Adjustments to Core Earnings
|
| |
|
Certain organizational expenses
|
| |
616,190
|
Adjusted Core Earnings
|
| |
$1,158,640
|
Basic weighted average shares of common stock outstanding (in shares, on a post-split basis)
|
| |
5,376,411
|
Adjusted Core Earnings per weighted Average Share (on a post-split basis)
|
| |
$0.22
|
(1)
|
Our Manager has agreed to waive the Incentive Compensation for the period from July 31, 2020 (date of commencement of operations) through December 31, 2020.
|
|
| |
Period from
July 31,
2020 to
September 30,
2020
|
Net Income / (loss)
|
| |
$2,106,250
|
Adjustments to reconcile net income / (loss) to net cash provided by / (used in) operating activities
|
| |
(2,162,678)
|
Net cash provided by / (used in) operating activities
|
| |
(56,428)
|
Net cash provided by / (used in) investing activities
|
| |
(642,660)
|
Net cash provided by / (used in) financing activities
|
| |
31,946,092
|
Change in cash, cash equivalents and restricted cash
|
| |
$31,247,004
|
|
| |
Less than
1 year
|
| |
1-3 years
|
| |
3-5 years
|
| |
More than
5 years
|
| |
Total
|
Unfunded Commitments
|
| |
$21,561,105
|
| |
—
|
| |
—
|
| |
—
|
| |
$21,561,105
|
Total
|
| |
$21,561,105
|
| |
—
|
| |
—
|
| |
—
|
| |
$21,561,105
|
•
|
Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that we have the ability to access.
|
•
|
Level 2—Valuations based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.
|
•
|
Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
|
|
| |
Restricted Stock
Options Granted
|
Non-vested
|
| |
16,474
|
Vested
|
| |
98,734
|
Forfeited
|
| |
—
|
Balance at September 30, 2020
|
| |
115,208
|
•
|
Market Drivers:
|
○
|
Increasing numbers of patients and customers purchasing cannabis in state legal programs
|
○
|
Increasing legalization of cannabis, including the recent legalization of medicinal and/or adult use cannabis, as applicable, by Arizona, Mississippi, Montana, New Jersey, and South Dakota in each of their most recent respective state elections.
|
○
|
Wide range of benefits for both medical and adult use
|
○
|
Growing medical applications
|
•
|
Market Challenges:
|
○
|
Stringent state-by-state regulation and lengthy license approval process
|
○
|
High cost and complex distribution channel
|
○
|
Large illicit market
|
•
|
Market Opportunities:
|
○
|
U.S. cannabis industry is estimated to have a total economic impact of greater than $106 billion by 2024
|
○
|
Interest-bearing loans as a type of loan in the cannabis industry increased to 37% in 2019 from 22% in 2017
|
○
|
Constrained public and private equity markets including lack of access to traditional debt capital
|
•
|
The Secure and Fair Enforcement (“SAFE”) Banking Act of 2019 would allow financial institutions legally to provide services to state-licensed and compliant.
|
○
|
The HEROES Act, passed by the House of Representatives for COVID-19 relief, includes those provisions from the SAFE Banking Act.
|
•
|
The Marijuana Opportunity, Reinvestment and Expungement Act would remove cannabis entirely from the list of scheduled substances under the Controlled Substances Act and eliminate criminal penalties for manufacturing, distributing, or possessing cannabis, and among other measures would also establish certain measures for social and criminal justice and impose a federal tax on cannabis products.
|
•
|
The Strengthening the Tenth Amendment Through Entrusting States (“STATES”) Act provides that the CSA's prohibitions “shall not apply to any person acting in compliance with state law relating to the manufacture, production, possession, distribution, dispensation, administration, or delivery of marijuana.” While cannabis would remain a CSA schedule I controlled substance, the STATES Act would permit state legal cannabis activities by creating a carve-out to the CSA, which in turn would remove the risk of federal anti-money-laundering and RICO claims. The STATES Act would not fully legalize cannabis on a national level, and would allow states to continue to prohibit cannabis or limit its legality.
|
•
|
Targeting loans for origination and investment that typically have the following characteristics:
|
○
|
principal balance greater than $10 million;
|
○
|
real estate collateral coverage of at least one times the principal balance;
|
○
|
secured by commercial real estate properties, including cannabis cultivation facilities, processing facilities and dispensaries; and
|
○
|
well-capitalized sponsors with substantial experience in particular real estate sectors and geographic markets.
|
•
|
Diversifying our financing sources with increased access to equity and debt capital, which may provide us with a lower overall cost of funding and the ability to hold larger loan sizes, among other things.
|
Origination
|
Underwriting
|
Investment Committee
|
Legal Documentation and
Post-Closing
|
||||
•
|
Direct origination platform works to create enhanced yields by originating and structuring loans, as well as putting in enhanced controls
|
•
|
Disciplined underwriting process leads to a highly selective approach
|
•
|
Focused on managing credit risk through comprehensive investment review process
|
•
|
Investment team works alongside external counsel to negotiate credit agreements and collateral liens
|
|
|
|
|
|
|
|
|
•
|
Platform drives increased deal flow, which provides for improved loan selectivity
|
•
|
Potential loans are screened based on four key criteria: company profile, state dynamics, regulatory matters and real estate asset considerations
|
•
|
The Investment Committee must approve each loan before commitment papers are issued
|
•
|
Emphasis is placed on financial covenants and limitations on actions that may be adverse to lenders
|
|
|
|
|
|
|
|
|
•
|
Allows for specific portfolio construction and a focus on higher quality companies
|
•
|
Other tools that we frequently use to verify data include, but are not limited to: appraisals, quality of earnings, environmental reports, site visits, comparable company analyses and background checks
|
•
|
Members of the Investment Committee currently include: Leonard M. Tannenbaum, Jonathan Kalikow and Robyn Tannenbaum. It is intended that the Investment Committee will be expanded to five members consisting of the three current members and our to-be-named Managing Director, Portfolio Management and General Counsel
|
•
|
Portfolio is proactively managed to monitor ongoing performance, in some instances, through seats on borrowers’ boards of directors or board observer rights
|
|
|
|
|
|
|
|
|
•
|
As of December 26, 2020, 34 active loans in pipeline at various stages in the diligence process
|
•
|
As of December 26, 2020, we had passed on 185 of 229 sourced loans due to, among other reasons, lack of collateral, lack of cash flow, stage of company, no previous experience and state dynamics
|
|
|
|
|
•
|
Borrower and Operations
|
○
|
Type of operations – cultivation, processing, manufacturing and distribution
|
○
|
Mix analysis – wholesale vs. retail
|
○
|
State regulatory approval
|
○
|
Quality of management – cultivation experience and financial expertise, among other factors
|
○
|
Brand analysis – owned brands or produce for others
|
○
|
Quality control analysis – testing, operational procedures, remediation procedures
|
○
|
Construction projects – historical ability to hit budget and timeline
|
•
|
Real Estate and Structure
|
○
|
Type of cultivation (outdoor, greenhouse, indoor), processing capabilities, and distribution abilities
|
○
|
Size, construction, and suitability of the facility
|
○
|
Total land and hard/soft costs analysis to determine total basis and estimate replacement costs
|
○
|
Visual and/or physical site visit to inspect the land, facilities, and specific systems in use
|
○
|
Real estate metrics:
|
•
|
Loan to Cost
|
•
|
Loan to Value (appraised for cannabis use)
|
•
|
Loan to Value (alternative use)
|
•
|
State by State Analysis
|
○
|
Legislative environment of every state a company operates in
|
○
|
Probability analysis of legislative changes in each state
|
○
|
Growing conditions and seasonality within the state
|
○
|
Local planning and permits
|
○
|
Current political climate and importance of cannabis
|
○
|
License dynamics – number and type (vertical, single)
|
•
|
Loan Analysis
|
○
|
Loan size and capital structure overview – current and pro forma
|
○
|
Loan economics – interest rate, OID, exit fees, prepayment penalties, etc.
|
○
|
Loan security – real estate, licenses, parent guaranty, cash flow, trademarks, etc.
|
○
|
Thorough covenant analysis and remedies to breach
|
○
|
Review of the agent and participants in the syndication process
|
○
|
Risks and mitigants of the loan – credit risk, business risk, structure risk, etc.
|
○
|
If the borrower offers us an Assigned Right to acquire warrants and/or equity of the borrower as part of the consideration for us to provide a loan to such borrower, we will sell the Assigned Right to a third-party buyer on the market or to one of our affiliates, subject to such affiliate’s separate approval process and our related transactions policy.
|
•
|
Financial Analysis and Metrics
|
○
|
Historical and projected cash flow analysis
|
○
|
Capital structure analysis – current and pro forma for the loan
|
○
|
Loans are structured with covenants such as maximum leverage ratio, debt service coverage ratio, fixed charge coverage ratio, minimum EBITDA, and minimum cash
|
○
|
Cost per gram of the product
|
○
|
Full financial model – vertically integrated, wholesaler, distributor, etc.
|
•
|
License Analysis
|
○
|
Fully examine the licenses owned in each state
|
○
|
Review the licenses under application in each state
|
○
|
Evaluate the transferability of license(s) held by the company
|
○
|
Analyze the valuation and marketplace for licenses in each state
|
•
|
Appraisal. An independent appraisal, or an update of an independent appraisal, that meets the requirements of the “Uniform Standards of Professional Appraisal Practice” as adopted by the Appraisal Standards Board of the Appraisal Foundation, or the guidelines in Title XI of the Financial Institutions Reform, Recovery, and Enforcement Act of 1989, is generally required in connection with the origination or acquisition of each loan. In some cases, however, the value of the subject property collateral may be established based on total cost basis, a cash flow analysis, a recent sales price or another method or benchmark of valuation, without reference to any appraisal report.
|
•
|
Environmental Assessment. A Phase I environmental assessment is performed by a qualified third- party consultant to identify and evaluate potential environmental issues in connection with the subject property collateral. Depending on the findings of the initial environmental assessment, any of the following may be required: additional environmental testing and review, such as a Phase II environmental assessment with respect to the property; an environmental insurance policy; remediation activities; the establishment of an operations and maintenance plan by the borrower; and/or a guaranty or reserve with respect to environmental matters. If a Phase I or Phase II report already exists from a qualified consultant, we may utilize the information in that report along with a reliance letter from the consultant who performed the report.
|
•
|
Engineering Assessment. In general, our Manager requires that an engineering firm inspect the subject property collateral to assess the structure, exterior walls, roofing, interior structure, parking, fire suppression systems, ADA compliance, and/or mechanical and electrical systems. Based on the resulting report, our Manager determines the appropriate response, which may include, but is not limited to, modifications to the contemplated loan terms, or additional reserve requirements for any recommended immediate repairs, corrections or replacements and any identified deferred maintenance.
|
•
|
Seismic Report. For investments in geographic regions that are known to be seismically active, we may retain third-party consultants to determine if earthquake insurance is required and, if required, the appropriate amount for the asset and situation.
|
•
|
Insurance. The borrower is required to provide to us evidence of, and our Manager typically reviews (with the assistance of both counsel and an independent insurance consultant), various forms of insurance, including: (i) title insurance insuring the lien of the subject property collateral; (ii) casualty insurance; (iii) flood insurance, if applicable and available; and (iv) business interruption or rent loss insurance. In addition, our Manager typically requires the borrower to maintain comprehensive general liability insurance against claims for personal and bodily injury, death or property damage occurring on, in or about the property in an amount customarily required by institutional lenders
|
(1)
|
All loans originated prior to July 31, 2020 were purchased from an affiliated entity at fair value plus accrued interest on July 31, 2020.
|
(2)
|
Loans originated before July 31, 2020 were acquired by us, net of unaccreted OID, which we accrete to income over the remaining term of the loan.
|
(3)
|
Assumes no prepayment penalties or early payoffs.
|
(4)
|
Loan to Subsidiary of Public Company C includes a $3.0 million initial funding of a $15.0 million aggregate loan commitment, which has interest that includes 3.0% PIK interest. The amortization of the loan exceeds PIK interest. The loan also includes two early advances totaling $9.0 million against the $15.0 million aggregate loan commitment, with a 19.0% interest rate. Statistics shown are for the $15.0 million loan commitment, except the weighted average interest rate, which is based on the weighted average interest rate as of December 26, 2020.
|
(5)
|
YTM IRR for Public Company A, subsidiary of Public Company C, Private Company A and Private Company D is enhanced by purchase discounts attributed to the fair value of equity warrants that were separated from the loans prior to our acquisition of such loans. The purchase discounts accrete to income over the respective remaining terms of such loans.
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
Real Estate
|
| |
|
|||||||||
Borrower
|
| |
Date
|
| |
Our
Total
Commitment
|
| |
Percentage
of
Total
Portfolio
|
| |
Total
Funded
Debt
Issuance
|
| |
Our
Percentage
of the
Total Loan
|
| |
Estimated
Real
Estate
Value(1)
|
| |
Real Estate
Collateral
Coverage
|
| |
Implied Real
Estate
Collateral
|
| |
Our
Real
Estate
Collateral
Coverage
|
| |
|
Public Co. A - Real Estate Loan(2)
|
| |
7/3/2019
|
| |
$2,940,000
|
| |
2.6%
|
| |
$30,000,000
|
| |
9.8%
|
| |
$107,000,000
|
| |
3.57x
|
| |
$10,486,000
|
| |
3.57x
|
| ||
Public Co. A - Equipment Loan
|
| |
8/5/2019
|
| |
$4,000,000
|
| |
3.5%
|
| |
$20,000,000
|
| |
20.0%
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| ||
Public Co. B(3)
|
| |
1/31/2020
|
| |
$5,000,000
|
| |
4.4%
|
| |
$20,000,000
|
| |
25.0%
|
| |
$53,100,000
|
| |
2.66x
|
| |
$13,275,000
|
| |
2.66x
|
| ||
Subsidiary of Public Co. C(4)
|
| |
2/12/2020
|
| |
$15,000,000
|
| |
13.3%
|
| |
$15,000,000
|
| |
100.0%
|
| |
$31,178,600
|
| |
2.08x
|
| |
$31,178,600
|
| |
2.08x
|
| ||
Private Co. A(5)
|
| |
5/8/2020
|
| |
$34,000,000
|
| |
30.1%
|
| |
$42,500,000
|
| |
80.0%
|
| |
$51,384,281
|
| |
1.21x
|
| |
$41,107,425
|
| |
1.21x
|
| ||
Private Co. B(6)
|
| |
9/10/2020
|
| |
$8,000,000
|
| |
7.1%
|
| |
$8,000,000
|
| |
100.0%
|
| |
$14,556,107
|
| |
1.82x
|
| |
$14,556,107
|
| |
1.82x
|
| ||
Private Co. C(7)
|
| |
11/5/2020
|
| |
$22,000,000
|
| |
19.5%
|
| |
$22,000,000
|
| |
100.0%
|
| |
$23,733,032
|
| |
1.08x
|
| |
$23,733,032
|
| |
1.08x
|
| ||
Subsidiary of Public Co. D(8)
|
| |
12/18/2020
|
| |
$10,000,000
|
| |
8.9%
|
| |
$120,000,000
|
| |
8.3%
|
| |
$26,058,332
|
| |
0.22x
|
| |
$2,171,528
|
| |
0.22x
|
| ||
Private Co. D(9)
|
| |
12/23/2020
|
| |
$12,000,000
|
| |
10.6%
|
| |
$12,000,000
|
| |
100.0%
|
| |
$7,500,000
|
| |
0.63x
|
| |
$7,500,000
|
| |
0.63x
|
| ||
|
| |
|
| |
$112,940,000
|
| |
100.0%
|
| |
$289,500,000
|
| |
39.0%
|
| |
$314,510,351
|
| |
1.09x
|
| |
$144,007,691
|
| |
1.28x
|
| ||
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
(1)
|
To the extent the applicable loan is intended to fund any acquisitions and/or construction, the applicable figure includes expected total basis on such future construction and/or acquisitions plus appraised value.
|
(2)
|
Public Company A real estate is based on cost basis.
|
(3)
|
Public Company B real estate is based on cost basis.
|
(4)
|
Subsidiary of Public Company C real estate is based on an existing cultivation property and the completed and stabilized value of a to-be-built facility. The anticipated completion date for the to-be-built facility is November 2021.
|
(5)
|
Private Company A real estate is based on the costs basis of various facilities constituting real estate collateral, plus anticipated capital expenditures for one facility that is being converted for cannabis cultivation purposes. The conversion is anticipated to be completed in February 2021.
|
(6)
|
Private Company B real estate is based on the expected total cost basis of a to-be-built facility, as completed. The anticipated completion date for the to-be-built facility is July 2021.
|
(7)
|
Private Company C real estate is based on the cost basis of two facilities, including the capital expenditures for one facility that is being converted for cannabis cultivation purposes. The construction of the to-be-converted facility is divided into six phases. The first phase was completed in December 2020, and the anticipated completion date for the remaining phases of construction is November 2021.
|
(8)
|
Subsidiary of Public Company D real estate based on total cost basis.
|
(9)
|
Private Company D real estate is based on appraised value.
|
Directors and Executive Officers
|
| |
Age
|
| |
Position/Title
|
Thomas L. Harrison
|
| |
73
|
| |
Lead Independent Director (Class I)
|
Leonard M. Tannenbaum
|
| |
49
|
| |
Chief Executive Officer, Chairman and Director (Class I)
|
Jonathan Kalikow
|
| |
50
|
| |
Head of Real Estate and Director (Class II)
|
Robert Levy
|
| |
55
|
| |
Independent Director (Class II)
|
Jodi Hanson Bond
|
| |
50
|
| |
Independent Director (Class II)
|
Alexander C. Frank
|
| |
62
|
| |
Independent Director (Class III)
|
Tomer J. Tzur
|
| |
49
|
| |
Independent Director (Class III)
|
Thomas Geoffroy
|
| |
46
|
| |
Chief Financial Officer and Treasurer
|
Robyn Tannenbaum
|
| |
35
|
| |
Managing Director, Origination, Investor Relations and Marketing
|
•
|
Class I, consisting of Mr. Harrison and Mr. Tannenbaum, with initial terms expiring at the annual meeting of stockholders to be held in 2021;
|
•
|
Class II, consisting of Mr. Kalikow, Mr. Levy and Ms. Bond, with initial terms expiring at the annual meeting of stockholders to be held in 2022; and
|
•
|
Class III, consisting of Mr. Frank and Mr. Tzur, with initial terms expiring at the annual meeting of stockholders to be held in 2023.
|
•
|
the integrity of our financial statements;
|
•
|
the qualifications and independence of any independent registered public accounting firm engaged by us;
|
•
|
the performance of our internal audit function and any independent registered public accounting firm;
|
•
|
the determination of the fair value of assets that are not publicly traded or for which current market values are not readily available; and
|
•
|
the entry and monitoring of related party transactions.
|
•
|
discharging the Board’s responsibilities relating to the compensation, if any, of our executive officers and directors;
|
•
|
overseeing the expense reimbursement of our Manager and its affiliates for compensation paid by such entities to their respective employees pursuant to our Management Agreement;
|
•
|
administering and implementing our incentive and equity-based compensation plans, including the 2020 Stock Incentive Plan; and
|
•
|
preparing reports on or relating to executive compensation required by the rules and regulations of the SEC.
|
•
|
identifying and recommending candidates to fill vacancies on our Board and for election by the stockholders;
|
•
|
recommending committee assignments for members to our Board;
|
•
|
facilitating our Board’s annual evaluation of the performance of our Board, its committees and individual directors; and
|
•
|
developing and recommending to our Board appropriate corporate governance policies, practices and procedures for our Company.
|
•
|
honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;
|
•
|
full, fair, accurate, timely and understandable disclosure in our SEC reports and other public communications;
|
•
|
compliance with applicable laws, rules and regulations;
|
•
|
prompt internal reporting of violations of the code of business conduct and ethics or applicable laws to appropriate persons identified in the code;
|
•
|
accountability for adherence to the code of business conduct and ethics;
|
•
|
the protection of our legitimate business interests, including its assets and corporate opportunities; and
|
•
|
confidentiality of information entrusted to directors, officers and employees, if any, by us and our borrowers.
|
•
|
any present or former director or officer who is made or threatened to be made a party to, or witness in, a proceeding by reason of his or her service in that capacity; or
|
•
|
any individual who, while a director or officer of our Company and at our request, serves or has served as a director, officer, partner, trustee, member or manager of another corporation, real estate investment trust, limited liability company, partnership, joint venture, trust, employee benefit plan or any other enterprise and who is made or threatened to be made a party to, or witness in, the proceeding by reason of his or her service in that capacity.
|
Name and Principal Position
|
| |
Year
|
| |
Salary
($)
|
| |
Bonus
($)
|
| |
Stock
Awards
($)
|
| |
Option
Awards
($)
|
| |
Non-Equity
Incentive Plan
Compensation
($)
|
| |
Nonqualified
Deferred
Compensation
Earnings ($)
|
| |
All Other
Compensation
($)
|
| |
Total
($)
|
Thomas Geoffroy(1)(2)
|
| |
2020
|
| |
$18,750
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
$18,750
|
(Chief Financial Officer)
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
(1)
|
Mr. Geoffroy is an employee of our Manager and is not paid compensation by us. Amounts in the columns entitled “Salary,” “Bonus” and “All Other Compensation” represent the compensation expense, including annual base salary and bonus, that is allocable to us based on the percentage of time he spent managing our affairs in 2020 in his capacity as Chief Financial Officer.
|
(2)
|
Mr. Geoffroy was granted a total of 3,090 options (on a pre-split basis, or 21,630 options, on a post-split basis), but the grant date fair market value of these awards were estimated at zero dollars per share. Mr. Geoffroy will be granted up to an additional 500 options (on a pre-split basis, or 3,500 options, on a post-split basis) immediately prior to the consummation of this offering.
|
|
| |
For the period from July 31, 2020
(date of commencement of operations)
to September 30, 2020(1)
|
Gross Base Management Fee
|
| |
$226,234
|
Base Management Fee Rebate(2)(3)
|
| |
84,167
|
Base Management Fees
|
| |
$142,067
|
Incentive Compensation(4)
|
| |
$—
|
(1)
|
Does not reflect the amendment to our Management Agreement, which will occur upon consummation of this offering. Upon consummation of this offering, our Management Agreement shall be amended such that (A) the Base Management Fees (i) shall be in an amount equal to 0.375% of our Equity, determined as of the last day of each quarter, and (ii) will be reduced by only 50% of the aggregate amount of any applicable fees counted toward the Base Management Fee Rebate; and (B) the Hurdle Amount used in calculating the Incentive Compensation will equal the product of (i) 2% and (ii) Adjusted Capital as of the last day of the immediately preceding fiscal quarter.
|
(2)
|
For the period from July 31, 2020 (date of commencement of operations) to September 30, 2020, our Base Management Fee was reduced by a Base Management Fee Rebate equal to 100% of the aggregate amount of any other fees earned and paid to our Manager during the applicable period resulting from the investment advisory services and general management services rendered by it under our Management Agreement, including any syndication, structuring, diligence, monitoring or agency fees relating to our loans, but excluding the Incentive Compensation. Upon the consummation of this offering, the Management Agreement will be amended such that the Base Management Fee Rebate will only equal 50% of the aggregate amount of any such fees described in the preceding sentence.
|
(3)
|
For the period from July 31, 2020 (date of commencement of operations) to September 30, 2020, the Base Management Fee Rebate consisted solely of agency fees charged to our borrowers and paid to our Manager for its role as agent to the lenders under the applicable credit agreements. We expect that the Base Management Fee Rebate will continue to consist solely of agency fees for the foreseeable future.
|
(4)
|
Our Manager has agreed to waive the Incentive Compensation for the period from July 31, 2020 (date of commencement of operations) through December 31, 2020.
|
•
|
we issue approximately $ million of our common stock in this offering, with net proceeds to us of approximately $ million, after deducting underwriting discounts and commissions and other estimated offering expenses payable by us, based on an assumed initial public offering price of $ per share, which is the mid-point of the estimated offering price range set forth on the front cover of this prospectus (or approximately $ million if the underwriters exercise their over-allotment option in full);
|
•
|
we distribute all of our net income to holders of our common stock;
|
•
|
our Manager does not earn or receive any fees for the 12 months following this offering resulting from the investment advisory services and general management services rendered by it under our Management Agreement other than Incentive Compensation;
|
•
|
there are no unrealized gains or losses, other non-cash items that have impacted stockholders’ equity, or one-time events pursuant to changes in GAAP, in each case during the 12 months following this offering; and
|
•
|
we do not repurchase or sell any shares of our capital stock during the 12 months following this offering.
|
•
|
“Adjusted Capital” means the sum of (i) cumulative gross proceeds generated from issuances of the shares of our capital stock (including any distribution reinvestment plan), less (ii) distributions to our investors that represent a return of capital and amounts paid for share repurchases pursuant to any share repurchase program.
|
•
|
“Core Earnings” means, for a given period, the net income (loss) for such period, computed in accordance with GAAP, excluding (i) non-cash equity compensation expense, (ii) Incentive Compensation, (iii) depreciation and amortization, (iv) any unrealized gains or losses or other non-cash items that are included in net income for the applicable reporting period, regardless of whether such items are included in other comprehensive income or loss, or in net income and (v) one-time events pursuant to changes in GAAP and certain non-cash charges, in each case as determined after discussions between our Manager and our independent directors and approval by a majority of our independent directors. For the avoidance of doubt, (a) the exclusion of depreciation and amortization in the calculation of Core Earnings shall only apply to depreciation and amortization related to our investments that are structured as debt to the extent that we foreclose upon the property or properties underlying such debt and (b) Core Earnings shall not exclude under clause (iv) above, in the case of investments with a deferred interest feature (such as OID, debt instruments with PIK interest and zero coupon securities), accrued income that we have not yet received in cash.
|
•
|
Adjusted Capital as of the last day of the immediately preceding fiscal quarter of $100 million; and
|
•
|
Core Earnings before the Incentive Compensation for the specified quarter representing a quarterly yield of 20.9% on Adjusted Capital as of the last day of the immediately preceding fiscal quarter.
|
|
| |
|
| |
Illustrative
Amount
|
| |
Calculation
|
1.
|
| |
What are the Core Earnings?
|
| |
$5,225,000
|
| |
Assumed to be a 5.2% quarterly or 20.9% per annum return on Adjusted Capital as of the last day of the immediately preceding fiscal quarter ($100 million).
|
|
| |
|
| |
|
| |
|
2.
|
| |
What is the Hurdle Amount?
|
| |
$2,000,000
|
| |
The hurdle rate (2.0% quarterly or 8.0% per annum) multiplied by Adjusted Capital as of the last day of the immediately preceding fiscal quarter ($100 million).
|
|
| |
|
| |
|
| |
|
3.
|
| |
What is the Catch-Up Amount?
|
| |
$666,667
|
| |
The catch-up incentive rate (50.0%) multiplied by the amount that Core Earnings ($5.2 million) exceeds the Hurdle Amount ($2 million), but is less than or equal to 166-2/3% of the Hurdle Amount (approximately $3.3 million).
|
|
| |
|
| |
|
| ||
4.
|
| |
What is the Excess Earnings Amount?
|
| |
$378,333
|
| |
The excess earnings incentive rate (20%) multiplied by the amount of Core Earnings ($5.2 million) that exceeds 166-2/3% of the Hurdle Amount (approximately $3.3 million).
|
|
| |
|
| |
|
| |
|
5.
|
| |
What is the Incentive Compensation?
|
| |
$1,045,000
|
| |
The sum of the Catch-Up Amount (approximately $666,667) and the Excess Earnings Amount (approximately $378,333).
|
•
|
each person known by us to beneficially own 5% or more of the outstanding shares of our common stock;
|
•
|
each member of our Board upon the consummation of this offering;
|
•
|
all of our current directors and executive officers as a group; and
|
•
|
the members of our Board upon the consummation of this offering and our executive officers as a group.
|
|
| |
Shares
Beneficially
Owned Before
Offering
|
| |
Shares
Beneficially
Owned After
Offering
Assuming No
Exercise of the
Underwriters’
Option
|
| |
Shares
Beneficially
Owned After
Offering
Assuming Full
Exercise of the
Underwriters’
Option
|
|||||||||
Name of Beneficial Owner
|
| |
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
5% Stockholders:
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Leonard M. Tannenbaum(1)
|
| |
4,749,458
|
| |
62.6%
|
| |
|
| |
|
| |
|
| |
|
Gamma Lending Holdco LLC(2)
|
| |
668,500
|
| |
10.8%
|
| |
|
| |
|
| |
|
| |
|
AFCG RM1, LLC(3)
|
| |
531,615
|
| |
8.6%
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Directors and Executive Officers:
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Leonard M. Tannenbaum(1)
|
| |
4,749,458
|
| |
62.6%
|
| |
|
| |
|
| |
|
| |
|
Jonathan Kalikow(2)
|
| |
668,500
|
| |
10.8%
|
| |
|
| |
|
| |
|
| |
|
Thomas L. Harrison(4)
|
| |
11,428
|
| |
*
|
| |
|
| |
|
| |
|
| |
|
Tomer J. Tzur(5)
|
| |
7,939
|
| |
*
|
| |
|
| |
|
| |
|
| |
|
Alexander C. Frank(6)
|
| |
8,085
|
| |
*
|
| |
|
| |
|
| |
|
| |
|
Jodi Hanson Bond(7)
|
| |
11,208
|
| |
*
|
| |
|
| |
|
| |
|
| |
|
Thomas Geoffroy
|
| |
3,269
|
| |
*
|
| |
|
| |
|
| |
|
| |
|
Robert Levy(8)
|
| |
1,400
|
| |
*
|
| |
|
| |
|
| |
|
| |
|
Robyn Tannenbaum(9)
|
| |
34,160
|
| |
*
|
| |
|
| |
|
| |
|
| |
|
All directors and executive officers as a group (9 persons)
|
| |
5,495,447
|
| |
72.0%
|
| |
|
| |
|
| |
|
| |
|
(*)
|
Represents beneficial ownership of less than 1%.
|
(1)
|
Includes (i) 3,342,500 shares of common stock, (ii) 776,958 shares of common stock which Mr. Tannenbaum has the right to acquire pursuant to outstanding and vested stock options that will be exercisable upon the consummation of this offering and (iii) up to 630,000 shares of common stock which Mr. Tannenbaum will have the right to acquire pursuant to stock options that will be granted immediately prior to the consummation of this offering and will become vested upon such grant and exercisable upon consummation of this offering.
|
(2)
|
Gamma Lending Holdco LLC, is a Delaware limited partnership (“GLO”), whose sole General Partner is GRE Lending Opportunities LLC, a Delaware limited liability company (“GLO GP”). GLO GP is a wholly owned subsidiary of Gamma Real Estate LLC (“GRE”), Jonathan Kalikow owns 50% of the economic and voting interests in GRE and N. Richard Kalikow, father of Jonathan Kalikow, owns the remaining 50% of the economic and voting interests of GRE.
|
(3)
|
AFCG RM1, LLC, is a Delaware limited liability company and the Manager serves as its manager. Mr. Tannenbaum is the sole manager of the Manager. Pursuant to the terms of AFCG RM1, LLC’s operating agreement, upon the consummation of this offering, the shares of our common stock held by AFCG RM1, LLC will be promptly distributed to its members and AFCG RM1, LLC will be dissolved. There are approximately 85 members of AFCG RM1, LLC, each of whom beneficially own less than 1% of the shares of our common stock. Mr. Tannenbaum disclaims beneficial ownership of those shares.
|
(4)
|
Includes (i) 10,028 shares of common stock and (ii) 700 shares of common stock which Mr. Harrison has the right to acquire pursuant to outstanding and vested stock options that will be exercisable upon the consummation of this offering and (iii) up to 700 shares of common stock which Mr. Harrison will have the right to acquire pursuant to stock options that will be granted immediately prior to the consummation of this offering and will become vested upon such grant and exercisable upon consummation of this offering.
|
(5)
|
Includes (i) 6,539 shares of common stock and (ii) 700 shares of common stock which Mr. Tzur has the right to acquire pursuant to outstanding and vested stock options that will be exercisable upon the consummation of this offering and (iii) up to 700 shares of common stock which Mr. Tzur will have the right to acquire pursuant to stock options that will be granted immediately prior to the consummation of this offering and will become vested upon such grant and exercisable upon consummation of this offering.
|
(6)
|
Includes (i) 6,685 shares of common stock and (ii) 700 shares of common stock which Mr. Frank has the right to acquire pursuant to outstanding and vested stock options that will be exercisable upon the consummation of this offering and (iii) up to 700 shares of common stock which Mr. Frank will have the right to acquire pursuant to stock options that will be granted immediately prior to the consummation of this offering and will become vested upon such grant and exercisable upon consummation of this offering.
|
(7)
|
Includes (i) 9,808 shares of common stock and (ii) 700 shares of common stock which Ms. Bond has the right to acquire pursuant to outstanding and vested stock options that will be exercisable upon the consummation of this offering and (iii) up to 700 shares of common stock which Ms. Bond will have the right to acquire pursuant to stock options that will be granted immediately prior to the consummation of this offering and will become vested upon such grant and exercisable upon consummation of this offering.
|
(8)
|
Includes the up to 1,400 shares of common stock which Mr. Levy will have the right to acquire pursuant to stock options that will be granted immediately prior to the consummation of this offering and will become vested upon such grant and exercisable upon consummation of this offering.
|
(9)
|
Includes (i) 20,160 shares of common stock which Mrs. Tannenbaum has the right to acquire pursuant to outstanding stock options that will be exercisable upon the consummation of this offering and (iii) up to 14,000 shares of common stock which Mrs. Tannenbaum will have the right to acquire pursuant to stock options that will be granted immediately prior to the consummation of this offering and will become vested upon such grant and exercisable upon consummation of this offering.
|
•
|
the holders of our common stock shall have the exclusive right to vote for the election of directors and on all other matters requiring stockholder action, each share entitling the holder thereof to cast one vote on each matter submitted to a vote of stockholders;
|
•
|
dividends or other distributions may be declared and paid or set apart for payment upon our common stock out of any assets or our funds legally available for the payment of distributions, but only when, as, and if, authorized by our Board; and
|
•
|
upon our voluntary or involuntary liquidation, dissolution or winding up, our net assets legally available for distribution shall, after the payment of or adequate provision for all known debts and liabilities and any preferential rights of the holders of any then-outstanding shares of our preferred stock, be distributed pro rata to the holders of our common stock.
|
•
|
After June 30, 2021, (1) no person, other than an Excepted Holder (defined below), shall Beneficially Own (defined below) or Constructively Own (defined below) shares of our capital stock in excess of the “Aggregate Stock Ownership Limit,” which is defined as 6.2% in value or number of shares, whichever is more restrictive, of the aggregate outstanding shares of our capital stock and (2) no Excepted Holder shall Beneficially Own or Constructively Own shares of our capital stock in excess of the Excepted Holder Limit (defined below) for such Excepted Holder.
|
•
|
No person shall Beneficially Own or Constructively Own shares of our capital stock to the extent that such Beneficial Ownership or Constructive Ownership of our capital stock would result in us (i) being Closely Held (defined below) after June 30, 2021 (without regard to whether the ownership interest is held during the last half of a taxable year), or (ii) otherwise failing to qualify as a REIT (including, but
|
•
|
Any transfer of shares of our capital stock that, if effective, would result in our capital stock being beneficially owned by less than 100 persons (determined under the principles of Section 856(a)(5) of the Code) after January 15, 2021 shall be void ab initio, and the intended transferee shall acquire no rights in such shares of our capital stock.
|
•
|
Any transfer of shares of our capital stock that, if effective, would cause our assets to be deemed “plan assets” within the meaning of Department of Labor regulation 20 C.F.R. 2510.3-101 for purposes of ERISA or Section 4975 of the Code shall be void ab initio, and the intended transferee shall acquire no rights in such shares of our capital stock.
|
•
|
then that number of shares of our capital stock the Beneficial Ownership or Constructive Ownership of which otherwise would cause such person to violate the ownership limitations (rounded up to the next whole share) shall be automatically transferred to a trust for the benefit of a charitable beneficiary, as described in the Charter, effective as of the close of business on the business day prior to the date of such transfer, and such person shall acquire no rights in such shares; or
|
•
|
if the transfer to the trust described in the preceding clause would not be effective for any reason to prevent violation of the Aggregate Stock Ownership Limit or the Excepted Holder Limit, as applicable, our being Closely Held or our otherwise failing to qualify as a REIT, then the transfer of that number of shares of our capital stock that otherwise would cause any person to violate such provisions of the Charter, shall be void ab initio, and the intended transferee shall acquire no rights in such shares of our capital stock.
|
•
|
to the extent that, upon a transfer of shares of our capital stock pursuant to the Charter, a violation of any provision of the Charter would nonetheless be continuing (for example, where the ownership of shares of our capital stock by a single trust would violate the 100 stockholder requirement applicable to REITs), then shares of our capital stock shall be transferred to that number of trusts, each having a distinct trustee and a charitable beneficiary or charitable beneficiaries that are distinct from those of each other trust, such that there is no violation of any provisions of the Charter.
|
•
|
Shares of our capital stock held in the trust will be issued and outstanding shares. The prohibited owner will not benefit economically from ownership of any shares of our capital stock held in the trust and will have no rights to distributions and no rights to vote or other rights attributable to the shares of our capital stock held in the trust. The trustee of the trust will exercise all voting rights and receive all distributions with respect to shares held in the trust for the exclusive benefit of the charitable beneficiary of the trust. Any distribution made before we discover that the shares have been transferred to a trust as described above must be repaid by the recipient to the trustee upon our demand. Subject to Maryland law, effective as of the date that the shares have been transferred to the trust, the trustee will have the authority to rescind as void any vote cast by a prohibited owner before our discovery that the shares have been transferred to the trust and to recast the vote in accordance with the desires of the trustee acting for the benefit of the charitable beneficiary of the trust. However, if we have already taken irreversible corporate action, then the trustee may not rescind and recast the vote.
|
•
|
one-tenth or more but less than one-third;
|
•
|
one-third or more but less than a majority; or
|
•
|
a majority or more of all voting power.
|
•
|
a classified board of directors;
|
•
|
a two-thirds vote requirement for removing a director;
|
•
|
a requirement that the number of directors be fixed only by vote of the board of directors;
|
•
|
a requirement that a vacancy on the board of directors be filled only by a vote of the remaining directors in office and for the remainder of the full term of the class of directors in which the vacancy occurred and until a successor is elected and qualifies; and
|
•
|
a majority requirement for the calling of a stockholder-requested special meeting of stockholders.
|
•
|
the act or omission of the director or officer was material to the matter giving rise to the proceeding and (a) was committed in bad faith or (b) was the result of active and deliberate dishonesty;
|
•
|
the director or officer actually received an improper personal benefit in money, property or services; or
|
•
|
in the case of any criminal proceeding, the director or officer had reasonable cause to believe that the act or omission was unlawful.
|
•
|
a written affirmation by the director or officer of his or her good faith belief that he or she has met the standard of conduct necessary for indemnification by us; and
|
•
|
a written undertaking by or on behalf of the director or officer to repay the amount paid or reimbursed by us if it is ultimately determined that the director or officer did not meet the standard of conduct.
|
•
|
any present or former director or officer who is made or threatened to be made a party to, or witness in, a proceeding by reason of his or her service in that capacity; or
|
•
|
any individual who, while a director or officer of our Company and at our request, serves or has served as a director, officer, partner, member, manager or trustee of another corporation, REIT, partnership, limited liability company, joint venture, trust, employee benefit plan or any other enterprise and who is made or threatened to be made a party to, or witness in, the proceeding by reason of his or her service in that capacity.
|
•
|
a citizen or resident of the United States;
|
•
|
a corporation or entity treated as a corporation for U.S. federal income tax purposes created or organized in or under the laws of the United States, any state thereof, or the District of Columbia;
|
•
|
an estate, the income of which is subject to U.S. federal income taxation regardless of its source; or
|
•
|
a trust if it (1) is subject to the primary supervision of a court within the United States, and one or more U.S. persons have authority to control all substantial decisions of the trust or (2) has a valid election in effect under applicable Treasury regulations to be treated as a U.S. person.
|
•
|
we will be taxed at normal corporate rates on any undistributed net income (including undistributed net capital gains);
|
•
|
if we fail to satisfy either the 75% or the 95% gross income tests (discussed below), but nonetheless maintain our qualification as a REIT because other requirements are met, we will be subject to a 100% tax on the greater of (1) the amount by which we fail the 75% test and (2) the amount by which we fail the 95% test, in either case, multiplied by a fraction intended to reflect our profitability;
|
•
|
if we should fail to satisfy the asset tests or other requirements applicable to REITs, as described below, yet nonetheless maintain our qualification as a REIT because there is reasonable cause for the failure and other applicable requirements are met, we may be subject to an excise tax;
|
•
|
we will be subject to a tax of 100% on net income from any “prohibited transaction;”
|
•
|
we will be subject to tax, at the highest corporate rate, on net income from (1) the sale or other disposition of “foreclosure property” (generally, property acquired by us through foreclosure or after a default on a loan secured by the property or a lease of the property and for which an election is in effect) that is held primarily for sale to customers in the ordinary course of business or (2) other non-qualifying income from foreclosure property;
|
•
|
if we fail to distribute during each calendar year at least the sum of (1) 85% of our REIT ordinary income for the year, (2) 95% of our REIT capital gain income for the year and (3) any undistributed taxable income from prior years, we will be subject to a 4% excise tax on the excess of the Required Distribution over the sum of (a) the amounts actually distributed plus (b) the amounts with respect to which certain taxes are imposed on us;
|
•
|
if we acquire any asset from a “C corporation” (that is, a corporation generally subject to the full corporate level tax) in a transaction in which the basis of the asset in our hands is determined by
|
•
|
if we fail to qualify for taxation as a REIT because we failed to distribute by the end of the relevant year any earnings and profits we inherited from a taxable C corporation during the year (e.g., by tax-free merger or tax-free liquidation), and the failure is not due to fraud with intent to evade tax, we generally may retain our REIT status by paying a special distribution, but we will be required to pay an interest charge on 50% of the amount of undistributed non-REIT earnings and profits;
|
•
|
a 100% tax may be imposed on certain transactions between us and our taxable REIT subsidiaries (“TRSs”) that do not reflect arm’s length terms;
|
•
|
we may be required to pay monetary penalties to the IRS in certain circumstances, including if we fails to satisfy the record keeping requirements intended to monitor our compliance with rules relating to the ownership of our common stock, as described below in “—Requirements for Qualification—Organizational Requirements”;
|
•
|
certain of our subsidiaries, if any, may be subchapter C corporations, the earnings of which could be subject to federal corporate income tax; and
|
•
|
we and our subsidiaries, if any, may be subject to a variety of taxes, including state, local and foreign income taxes, property taxes and other taxes on our assets and operations and could also be subject to tax in situations and on transactions not presently contemplated.
|
(1)
|
that is managed by one or more trustees or directors;
|
(2)
|
the beneficial ownership of which is evidenced by transferable shares, or by transferable certificates of beneficial interest;
|
(3)
|
that would be taxable as a domestic corporation, but for Sections 856 through 860 of the Code;
|
(4)
|
that is neither a financial institution nor an insurance company subject to specified provisions of the Code;
|
(5)
|
the beneficial ownership of which is held by 100 or more persons;
|
(6)
|
during the last half of each taxable year not more than 50% in value of the outstanding stock of which is owned, directly or indirectly, or by application of certain constructive ownership rules, by five or fewer individuals (as defined in the Code to include some entities that would not ordinarily be considered “individuals”); and
|
(7)
|
that meets other tests, described below, regarding the nature of its income and assets.
|
•
|
75% Gross Income Test. At least 75% of our gross income (excluding gross income from prohibited transactions, income from certain hedging transactions and certain foreign currency gains) must consist of income derived directly or indirectly from investments relating to real property or mortgages on real property (generally including rents from real property, dividends from other REITs, and, in some circumstances, interest on mortgages), or some types of temporary investment income.
|
•
|
95% Gross Income Test. At least 95% of our gross income (excluding gross income from prohibited transactions, income from certain hedging transactions and certain foreign currency gains) must consist of items that satisfy the 75% gross income test and certain other items, including dividends, interest and gain from the sale or disposition of stock or securities (or from any combination of these types of income).
|
•
|
following our identification of the failure to meet the 75% or 95% gross income tests for any taxable year, we file a schedule with the IRS setting forth each item of our gross income for purposes of the 75% or 95% gross income tests for such taxable year; and
|
•
|
our failure to meet these tests was due to reasonable cause and not willful neglect.
|
•
|
at least 75% of the value of our total assets must be represented by real estate assets (including (1) our allocable share of real estate assets held by partnerships in which we own an interest, (2) stock or debt instruments held for not more than one year purchased with the proceeds of our stock offering or long-term (at least five years) debt offering, cash, cash items and government securities, (3) stock in other REITs and (4) certain mortgage-backed securities and loans);
|
•
|
not more than 25% of our total assets may be represented by securities other than those in the 75% asset class;
|
•
|
of the investments included in the 25% asset class, the value of any one issuer’s securities owned by us may not exceed 5% of the value of our total assets (unless the issuer is a TRS), and we may not own more than 10% of the vote or value of any one issuer’s outstanding securities (unless the issuer is a TRS or we can avail ourselves of the rules relating to certain securities and “straight debt” summarized below);
|
•
|
not more than 20% of the value of our total assets may be represented by securities of one or more TRS; and
|
•
|
not more than 25% of the value of our total assets may be represented by debt instruments of publicly offered REITs that are not secured by mortgages on real property or interests in real property.
|
•
|
Distributions out of current or accumulated earnings and profits (and not designated as capital gain dividends) generally constitute ordinary dividend income to U.S. Holders and will generally not be eligible for the dividends received deduction for corporations or the preferential tax rate for “qualified dividend income” (other than ordinary dividends attributable to dividends from taxable corporations, such as TRSs and to income upon which we have paid corporate income tax). However, under the Tax Cuts and Jobs Act of 2017 (“TCJA”), stockholders that are individuals, trusts or estates generally may deduct up to 20% of certain qualified business income, including “qualified REIT dividends” (generally, dividends received by a REIT shareholder that are not designated as capital gain dividends or qualified dividend income), subject to certain limitations.
|
•
|
Distributions in excess of current and accumulated earnings and profits are not taxable to a U.S. Holder to the extent that they do not exceed the adjusted basis of the U.S. Holder’s shares, but rather reduce the adjusted basis of those shares. To the extent that distributions in excess of current and accumulated earnings and profits exceed the adjusted basis of a U.S. Holder’s shares, they are to be included in income as long-term capital gain (or short-term capital gain if the shares have been held for one year or less).
|
•
|
Distributions designated as capital gain dividends constitute long-term capital gains (to the extent they do not exceed our actual net capital gain for the taxable year) without regard to the period for which the U.S. Holder has held our stock. Corporate U.S. Holders may be required to treat up to 20% of some capital gain dividends as ordinary income. Capital gains dividends attributable to the sale of depreciable real property held for more than 12 months are subject to a 25% U.S. federal income tax rate for U.S. Holders who are individuals, trusts or estates, to the extent of previously claimed depreciation deductions.
|
•
|
If we elect to retain and pay income tax on our net long-term capital gain, each holder of our common stock would: (1) include our proportionate share of our undistributed long-term capital gain (to the extent we make a timely designation of such gain to the stockholder) in our income, (2) be deemed to have paid our proportionate share of the tax that we paid on such gain and (3) be allowed a credit for our proportionate share of the tax deemed to have been paid, with an adjustment made to increase the holder’s basis in our stock by the difference between (a) the amount of capital gain included in income and (b) the amount of tax deemed paid by the holder.
|
•
|
Distributions declared by us in October, November or December of any year payable to a U.S. Holder of record on a specified date in October, November or December will be treated as both paid by us and received by the U.S. Holder on December 31 of that year, provided that the distribution is actually paid by us during January of the following calendar year.
|
•
|
evidencing that such Non-U.S. Holder is eligible for an exemption or reduced rate under an applicable income tax treaty, generally an IRS Form W-8BEN or Form W-8BEN-E (in which case we will withhold at the lower treaty rate); or
|
•
|
claiming that the distribution is income that is effectively connected with the Non-U.S. Holder’s conduct of a trade or business in the United States, generally an IRS Form W-8ECI (in which case we will not withhold tax).
|
•
|
the gain is effectively connected with the Non-U.S. Holder’s U.S. trade or business, in which case, unless an applicable income tax treaty provides otherwise, the Non-U.S. Holder will be subject to the same treatment as U.S. holders with respect to such gain and may be subject to the 30% branch profits tax on its effectively connected earnings and profits, subject to adjustments, in the case of a foreign corporation; or
|
•
|
the Non-U.S. Holder is a nonresident alien individual who was present in the United States for 183 days or more during the taxable year and meets certain other criteria, in which case the Non-U.S. Holder will incur a 30% tax on his or her capital gains derived from sources within the United States (net of certain losses derived from sources within the United States), unless an applicable income tax treaty provides otherwise.
|
Underwriter
|
| |
Number of
Shares
|
JMP Securities LLC
|
| |
|
Ladenburg Thalmann & Co., Inc.
|
| |
|
Seaport Global Securities LLC
|
| |
|
Total
|
| |
|
|
| |
Per
Share
|
| |
Without
Option
|
| |
With
Option
|
Public offering price
|
| |
$
|
| |
$
|
| |
$
|
Underwriting discount
|
| |
$
|
| |
$
|
| |
$
|
Proceeds, before expenses, to us
|
| |
$
|
| |
$
|
| |
$
|
•
|
offer, pledge, sell or contract to sell any common stock;
|
•
|
sell any option or warrant to purchase any common stock;
|
•
|
purchase any option or warrant to sell any common stock;
|
•
|
grant any option or warrant for the sale of any common stock;
|
•
|
lend or otherwise transfer or dispose of any common stock;
|
•
|
exercise any right with respect to the registration of any common stock or other securities; or
|
•
|
enter into any swap or other agreement or transaction that transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of any common stock whether any such swap, agreement or transaction is to be settled by the delivery of shares of common stock or other securities, in cash or otherwise.
|
•
|
estimates of the business potential and earnings prospects of our Company;
|
•
|
the history of, and the prospects for, our Company and the industry in which we compete;
|
•
|
an assessment of our management, its past and present operations, and the prospects for, and timing of, our future revenues;
|
•
|
the present state of our development; and
|
•
|
the above factors in relation to market values and various valuation measures of other companies engaged in activities similar to ours.
|
|
| |
September 30,
2020
|
Assets
|
| |
|
Loans held at fair value (cost of $45,539,161, net)
|
| |
$47,102,961
|
Loan receivable at carrying value (less allowance for credit loss of $0 at September 30, 2020)
|
| |
3,559,156
|
Cash and cash equivalents
|
| |
31,247,004
|
Interest receivable
|
| |
783,673
|
Prepaid expenses and other assets
|
| |
25,029
|
Total assets
|
| |
$82,717,823
|
|
| |
|
Liabilities
|
| |
|
Interest reserve
|
| |
$1,400,000
|
Accrued management fees, net
|
| |
142,067
|
Accrued direct administrative expenses
|
| |
202,534
|
Accounts payable and other liabilities
|
| |
118,040
|
Total liabilities
|
| |
1,862,641
|
|
| |
|
Stockholders’ Equity
|
| |
|
Preferred stock, par value $0.01 per share, 10,000 shares authorized at September 30, 2020 and 0 shares issued and outstanding at September 30, 2020
|
| |
—
|
Common stock, par value $0.01 per share, 15,000,000 shares authorized at September 30, 2020 and 768,059 shares issued and outstanding at September 30, 2020
|
| |
7,681
|
Additional paid-in-capital
|
| |
78,741,251
|
Accumulated earnings / (deficit)
|
| |
2,106,250
|
Total stockholders’ equity
|
| |
80,855,182
|
Total liabilities and stockholders’ equity
|
| |
$82,717,823
|
|
| |
Period from
July 31,
2020 to
September 30,
2020
|
Revenue
|
| |
|
Interest Income
|
| |
$1,594,769
|
Total revenue
|
| |
1,594,769
|
|
| |
|
Expenses
|
| |
|
Management fees, net (less rebate of $84,167)
|
| |
142,067
|
General and administrative expense
|
| |
204,262
|
Organizational expense
|
| |
616,190
|
Professional fees
|
| |
89,800
|
Total expenses
|
| |
1,052,319
|
|
| |
|
Net realized and change in unrealized gains / (losses) on loans at fair value
|
| ||
Change in unrealized gains / (losses) on loans at fair value, net
|
| |
1,563,800
|
Total net realized and change in unrealized gains (losses) on loans at fair value
|
| |
1,563,800
|
|
| |
|
Net Income / (loss) before income taxes
|
| |
2,106,250
|
Income tax expense
|
| |
—
|
Net Income / (loss)
|
| |
$2,106,250
|
|
| |
|
Earnings per common share:
|
| |
|
Basic earnings per common share (in dollars per share)
|
| |
$2.74
|
|
| |
|
Weighted average number of common shares outstanding:
|
| |
|
Basic weighted average shares of common stock outstanding (in shares)
|
| |
768,059
|
|
| |
Common Stock
|
| |
Additional
Paid-In-
Capital
|
| |
Accumulated
Earnings (Deficit)
|
| |
Total
Stockholders’
Equity
|
|||
|
| |
Shares
|
| |
Amount
|
| ||||||||
Balance at July 31, 2020 (commencement of operations)
|
| |
—
|
| |
$—
|
| |
$—
|
| |
$—
|
| |
$—
|
Issuance of common stock
|
| |
768,059
|
| |
7,681
|
| |
78,741,251
|
| |
—
|
| |
78,748,932
|
Net income / (loss)
|
| |
—
|
| |
—
|
| |
—
|
| |
2,106,250
|
| |
2,106,250
|
Balance at September 30, 2020
|
| |
768,059
|
| |
$7,681
|
| |
$78,741,251
|
| |
$2,106,250
|
| |
$80,855,182
|
|
| |
Period from
July 31,
2020 to
September 30,
2020
|
Operating activities:
|
| |
|
Net income / (loss)
|
| |
$2,106,250
|
|
| |
|
Adjustments to reconcile net income / (loss) to net cash provided by / (used in) operating activities:
|
| |
|
Change in unrealized gains / (losses) on loans at fair value, net
|
| |
(1,563,800)
|
Accretion of deferred loan origination fees and other discounts
|
| |
(173,110)
|
PIK interest
|
| |
(79,707)
|
|
| |
|
Changes in operating assets and liabilities
|
| |
|
Interest receivable
|
| |
(783,673)
|
Prepaid expenses and other assets
|
| |
(25,029)
|
Accrued management fees, net
|
| |
142,067
|
Accrued direct administrative expenses
|
| |
202,534
|
Accounts payable and other liabilities
|
| |
118,040
|
Net cash provided by / (used in) operating activities
|
| |
(56,428)
|
|
| |
|
Cash flows from investing activities:
|
| |
|
Issuance of and fundings on loans
|
| |
(780,000)
|
Principal repayment of loans
|
| |
137,340
|
Net cash provided by / (used in) investing activities
|
| |
(642,660)
|
|
| |
|
Cash flows from financing activities:
|
| |
|
Issuance of common stock
|
| |
31,946,092
|
Net cash provided by / (used in) financing activities
|
| |
31,946,092
|
|
| |
|
Change in cash, cash equivalents and restricted cash
|
| |
31,247,004
|
Cash, cash equivalents and restricted cash, beginning of period
|
| |
—
|
Cash, cash equivalents and restricted cash, end of period
|
| |
$31,247,004
|
|
| |
|
Supplemental disclosure of non-cash financing and investing activity
|
| |
|
Loans acquired for issuance of shares of common stock
|
| |
$46,802,840
|
Interest reserve withheld from funding of loan
|
| |
$1,400,000
|
|
| |
|
Supplemental information:
|
| |
|
Interest paid during the period
|
| |
$—
|
Income taxes paid during the period
|
| |
$—
|
1.
|
2.
|
SIGNIFICANT ACCOUNTING POLICIES
|
•
|
Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.
|
•
|
Level 2—Valuations based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.
|
•
|
Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
|
3.
|
LOANS HELD AT FAIR VALUE
|
|
| |
As of September 30, 2020
|
|||||||||
|
| |
Fair Value(2)
|
| |
Carrying
Value(1)
|
| |
Outstanding
Principal(1)
|
| |
Weighted Average
Remaining Life
(Years)(3)
|
Senior Term Loan
|
| |
$47,102,961
|
| |
$45,539,161
|
| |
$48,660,311
|
| |
2.7
|
Total loans held at fair value
|
| |
$47,102,961
|
| |
$45,539,161
|
| |
$48,660,311
|
| |
2.7
|
(1)
|
The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted purchase discount, deferred loan fees and loan origination costs
|
(2)
|
Refer to Footnote 12
|
(3)
|
Weighted average remaining life is calculated based on the fair value of the loans as of September 30, 2020
|
|
| |
Principal
|
| |
Origination
Costs and Loan
Fees
|
| |
Fair Value
|
Loans
|
| |
$46,080,604
|
| |
$(2,974,054)
|
| |
$43,106,550
|
Change in unrealized gains / (losses) on loans at fair value, net
|
| |
—
|
| |
—
|
| |
1,563,800
|
Additional funding
|
| |
2,500,000
|
| |
(320,000)
|
| |
2,180,000
|
Accretion of original issue discount
|
| |
—
|
| |
172,904
|
| |
172,904
|
PIK Interest
|
| |
79,707
|
| |
—
|
| |
79,707
|
Total loans held at fair value
|
| |
$48,660,311
|
| |
$(3,121,150)
|
| |
$47,102,961
|
|
| |
Location
|
| |
Fair Value(2)
|
| |
Carrying
Value(1)
|
| |
Outstanding
Principal(1)
|
| |
Interest
Rate
|
| |
Maturity
Date(3)
|
| |
Payment
Terms(4)
|
Senior Term Loan
|
| |
Multi State
|
| |
$21,841,606
|
| |
$20,986,986
|
| |
$23,220,311
|
| |
17.0%(6)
|
| |
5/8/2024
|
| |
P/I
|
Senior Term Loan
|
| |
MI
|
| |
2,414,370
|
| |
2,188,889
|
| |
2,500,000
|
| |
17.0%(7)
|
| |
9/1/2023
|
| |
P/I
|
Senior Term Loan
|
| |
NV
|
| |
2,856,210
|
| |
2,894,484
|
| |
2,940,000
|
| |
10.5%(8)
|
| |
6/27/2021
|
| |
I/O
|
Senior Term Loan
|
| |
Multi State
|
| |
5,007,500
|
| |
4,944,444
|
| |
5,000,000
|
| |
16.0%
|
| |
7/24/2021
|
| |
P/I
|
Senior Term Loan
|
| |
FL
|
| |
7,668,275
|
| |
7,524,358
|
| |
8,000,000
|
| |
18.1%(9)
|
| |
2/18/2025
|
| |
P/O
|
Senior Term Loan(5)
|
| |
Multi State
|
| |
7,315,000
|
| |
7,000,000
|
| |
7,000,000
|
| |
13.0%
|
| |
1/10/2024
|
| |
I/O
|
Total loans held at fair value
|
| |
|
| |
$47,102,961
|
| |
$45,539,161
|
| |
$48,660,311
|
| |
|
| |
|
| |
|
(1)
|
The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted purchase discount, deferred loan fees and loan origination costs
|
(2)
|
Refer to Footnote 12
|
(3)
|
Certain loans are subject to contractual extension options and may be subject to performance based or other conditions as stipulated in the loan agreement. Actual maturities may differ from contractual maturities stated herein as certain borrowers may have the right to prepay with or without paying a prepayment penalty. The Company may also extend contractual maturities and amend other terms of the loans in connection with loan modifications.
|
(4)
|
I/O = interest only, P/I = principal and interest. P/I loans may include interest only periods for a portion of the loan term.
|
(5)
|
As of September 30, 2020, this senior term loan was held for sale.
|
(6)
|
Base interest rate of 13% and PIK interest rate of 4%
|
(7)
|
Base interest rate of 13% and PIK interest rate of 4%
|
(8)
|
Base interest rate of 8% plus LIBOR (LIBOR floor of 2.5%)
|
(9)
|
Base interest rate of 13.5% and PIK interest rate of 3%
|
4.
|
LOAN RECEIVABLE AT CARRYING VALUE
|
|
| |
Principal
|
| |
Origination
Costs and Loan
Fees
|
| |
Carrying
Value
|
Loan receivable
|
| |
$3,700,718
|
| |
$(4,428)
|
| |
$3,696,290
|
Principal repayment of loans
|
| |
(137,340)
|
| |
—
|
| |
(137,340)
|
Accretion of original issue discount
|
| |
—
|
| |
206
|
| |
206
|
Total loans receivable at carry value
|
| |
$3,563,378
|
| |
$(4,222)
|
| |
$3,559,156
|
5.
|
INTEREST RECEIVABLE
|
|
| |
As of
September 30,
2020
|
Interest receivable
|
| |
$660,545
|
PIK receivable
|
| |
91,984
|
Unused fees
|
| |
31,144
|
Total interest receivable
|
| |
$783,673
|
6.
|
INTEREST RESERVE
|
|
| |
For the
period from
July 31,
2020 to
September 30,
2020
|
Initial reserves
|
| |
$—
|
New reserves
|
| |
1,400,000
|
Reserves disbursed
|
| |
—
|
Total Interest reserve
|
| |
$1,400,000
|
7.
|
DEBT
|
8.
|
COMMITMENTS AND CONTINGENCIES
|
|
| |
As of
September 30,
2020
|
Total original loan commitments
|
| |
$73,940,000
|
Less: drawn commitments
|
| |
(52,378,895)
|
Total undrawn commitments
|
| |
$21,561,105
|
9.
|
STOCKHOLDERS’ EQUITY
|
|
| |
Restricted
Stock Options
Granted
|
Non-vested
|
| |
16,474
|
Vested
|
| |
98,734
|
Forfeited
|
| |
—
|
Balance at September 30, 2020
|
| |
115,208
|
10.
|
EARNINGS PER SHARE
|
|
| |
Period from
July 31,
2020 to
September 30,
2020
|
Net income / (loss) attributable to common stockholders
|
| |
$2,106,250
|
Divided by:
|
| |
|
Basic weighted average shares of common stock outstanding
|
| |
768,059
|
Basic earnings per common share
|
| |
$2.74
|
11.
|
INCOME TAX
|
12.
|
FAIR VALUE
|
|
| |
As of September 30, 2020
|
||||||||||||
|
| |
Fair Value
|
| |
Primary
Valuation
Techniques
|
| |
Input
|
| |
Unobservable Input
|
|||
|
Estimated Range
|
| |
Weighted Average
|
|||||||||||
Senior Term Loan
|
| |
$47,102,961
|
| |
Yield analysis
|
| |
Market Yield
|
| |
14.5% - 22.54%
|
| |
19.8%
|
Total loans at fair value
|
| |
$47,102,961
|
| |
|
| |
|
| |
|
| |
|
|
| |
Fair Value Measurement Using
|
|||||||||
|
| |
Total
|
| |
Level 1
|
| |
Level 3
|
| |
Level 3
|
Loans held at fair value
|
| |
$47,102,961
|
| |
—
|
| |
—
|
| |
$47,102,961
|
Total
|
| |
$47,102,961
|
| |
—
|
| |
—
|
| |
$47,102,961
|
|
| |
For the
period from
July 31,
2020 to
September 30,
2020
|
Loans
|
| |
$43,106,550
|
Change in unrealized gains / (losses) on loans at fair value, net
|
| |
1,563,800
|
Additional funding
|
| |
2,500,000
|
Origination fees and discounts, net of costs
|
| |
(320,000)
|
Accretion of original issue discount
|
| |
172,904
|
PIK Interest
|
| |
79,707
|
Total loans using Level 3 inputs
|
| |
$47,102,961
|
13.
|
RELATED PARTY TRANSACTIONS
|
|
| |
Incurred for
the period
from
July 31,
2020 to
September 30,
2020
|
| |
Payable as of
September 30,
2020
|
Affiliate Payments
|
| |
|
| |
|
Management fees
|
| |
$226,234
|
| |
$226,234
|
Less other fees earned and paid to the Manager
|
| |
(84,167)
|
| |
(84,167)
|
General and administrative expenses reimbursed to Manager
|
| |
165,434
|
| |
165,434
|
Total
|
| |
$307,501
|
| |
$307,501
|
14.
|
DIVIDENDS AND DISTRIBUTIONS
|
15.
|
SUBSEQUENT EVENTS
|
Item 31.
|
Other Expenses of Issuance and Distribution
|
|
| |
Amount to be
Paid
|
SEC Registration Fee
|
| |
$12,546.50
|
FINRA filing fee
|
| |
$17,750.00
|
Nasdaq listing fee
|
| |
*
|
Printing
|
| |
*
|
Legal fees and expenses
|
| |
*
|
Accounting fees and expenses
|
| |
*
|
Transfer agent and registrar fees
|
| |
*
|
Miscellaneous expenses
|
| |
*
|
Total:
|
| |
$*
|
*
|
To be filed by amendment.
|
Item 32.
|
Sales to Special Parties.
|
Item 33.
|
Recent Sales of Unregistered Securities.
|
Item 34.
|
Indemnification of Directors and Officers.
|
•
|
the act or omission of the director or officer was material to the matter giving rise to the proceeding and (a) was committed in bad faith or (b) was the result of active and deliberate dishonesty;
|
•
|
the director or officer actually received an improper personal benefit in money, property or services; or
|
•
|
in the case of any criminal proceeding, the director or officer had reasonable cause to believe that the act or omission was unlawful.
|
•
|
any present or former director or officer who is made or threatened to be made a party to, or witness in, a proceeding by reason of his or her service in that capacity; or
|
•
|
any individual who, while a director or officer of our Company and at our request, serves or has served as a director, officer, partner, trustee, member or manager of another corporation, real estate investment trust, limited liability company, partnership, joint venture, trust, employee benefit plan or any other enterprise and who is made or threatened to be made a party to, or witness in, the proceeding by reason of his or her service in that capacity.
|
Item 35.
|
Treatment of Proceeds from Stock Being Registered.
|
Item 36.
|
Financial Statement and Exhibits.
|
(a)
|
Financial Statements. See page F-1 for an index of the financial statements included in the registration statement.
|
(b)
|
Exhibit Index.
|
Exhibit No.
|
| |
Document
|
| |
Form of Underwriting Agreement.
|
|
| |
Articles of Incorporation of AFC Gamma, Inc., as currently in effect.
|
|
3.2*
|
| |
Form of Articles of Amendment and Restatement of AFC Gamma, Inc., to be effective upon the completion of this offering.
|
| |
Bylaws of AFC Gamma, Inc., as currently in effect.
|
|
3.4*
|
| |
Form of Amended and Restated Bylaws of AFC Gamma, Inc., to be effective upon completion of this offering.
|
4.1*
|
| |
Form of Common Stock Certificate of the Registrant.
|
5.1*
|
| |
Opinion of Venable LLP
|
8.1*
|
| |
Opinion of O’Melveny & Myers LLP with respect to tax matters.
|
10.1*
|
| |
Amended and Restated Management Agreement, dated , 2020 by and between AFC Gamma, Inc. and AFC Management, LLC.
|
10.2*
|
| |
Form of Indemnification Agreement between the Registrant and each of its directors and executive officers.
|
10.3*
|
| |
Form of Indemnification Agreement between Registrant and each of the Investment Committee members.
|
| |
Form of Registration Rights Agreement, by and among AFC Gamma, Inc. and the holders thereto.
|
|
10.5*§
|
| |
2020 Stock Incentive Plan
|
| |
Secured Revolving Credit Agreement, dated August 18, 2020, by and among AFC Gamma, Inc., as borrower, AFC Finance, LLC, as agent, and AFC Finance, LLC and Jonathan Kalikow, as lenders.
|
|
| |
List of Subsidiaries of the Registrant.
|
|
| |
Consent of CohnReznick LLP, independent registered public accounting firm.
|
|
23.2*
|
| |
Consent of Venable LLP (included in Exhibit 5.1).
|
23.4*
|
| |
Consent of O’Melveny & Myers (included in Exhibit 8.1).
|
| |
Power of Attorney (included on the signature page).
|
*
|
To be filed by amendment.
|
§
|
Management contract or compensatory plan or arrangement
|
Item 37.
|
Undertakings.
|
1.
|
For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.
|
2.
|
For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
|
|
| |
AFC GAMMA, INC.
|
|||
|
| |
|
| |
|
|
| |
By:
|
| |
/s/ Leonard M. Tannenbaum
|
|
| |
|
| |
Name: Leonard M. Tannenbaum
|
|
| |
|
| |
Title: Chief Executive Officer and Chairman
|
Signature
|
| |
Title
|
| |
Date
|
|
| |
|
| |
|
/s/ Leonard M. Tannenbaum
|
| |
Chief Executive Officer and Director
(Principal Executive Officer)
|
| |
December 28, 2020
|
Leonard M. Tannenbaum
|
| |||||
|
| |
|
| |
|
/s/ Thomas Geoffroy
|
| |
Chief Financial Officer and Treasurer
(Principal Financial and Accounting Officer)
|
| |
December 28, 2020
|
Thomas Geoffroy
|
| |||||
|
| |
|
| |
|
/s/ Jonathan Kalikow
|
| |
Head of Real Estate and Director
|
| |
December 28, 2020
|
Jonathan Kalikow
|
| |||||
|
| |
|
| |
|
/s/ Robert Levy
|
| |
Director
|
| |
December 28, 2020
|
Robert Levy
|
| |||||
|
| |
|
| |
|
/s/ Jodi Hanson Bond
|
| |
Director
|
| |
December 28, 2020
|
Jodi Hanson Bond
|
| |||||
|
| |
|
| |
|
/s/ Thomas Harrison
|
| |
Director
|
| |
December 28, 2020
|
Thomas Harrison
|
| |||||
|
| |
|
| |
|
/s/ Alexander Frank
|
| |
Director
|
| |
December 28, 2020
|
Alexander Frank
|
| |||||
|
| |
|
| |
|
/s/ Tomer Tzur
|
| |
Director
|
| |
December 28, 2020
|
Tomer Tzur
|
|
Very truly yours,
|
||
AFC GAMMA, INC.
|
||
By:
|
||
Name:
|
||
Title:
|
||
AFC MANAGEMENT, LLC
|
||
By:
|
||
Name:
|
||
Title:
|
Accepted:
|
||
JMP Securities LLC
|
||
For itself and as Representative
|
||
of the several Underwriters named
|
||
in Schedule I hereto
|
||
By:
|
||
Authorized Representative
|
REIT Board
|
|
Class
|
Leonard Tannenbaum
|
|
I
|
Thomas Harrison
|
|
I
|
James Velgot
|
II
|
|
James Castro-Blanco
|
II
|
|
Jonathan Kalikow
|
II
|
|
Alexander Frank
|
|
III
|
Tomer Tzur
|
III
|
|
|
|
/s/Leonard Tannenbaum
|
|
|
|
Leonard Tannenbaum, Incorporator
|
COMPANY:
|
AFC Gamma, Inc.
|
|
By:
|
||
Name:
|
||
Title:
|
HOLDER:
|
|
|
By:
|
||
Name:
|
||
Title:
|
First Closing |
|
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
|
|
|
Second Closing |
|
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
|
|
|
Page
|
||
ARTICLE I DEFINITIONS; CONSTRUCTION
|
1
|
|
Section 1.1
|
Definitions
|
1
|
Section 1.2
|
Other Definitional Provisions
|
6
|
Section 1.3
|
Accounting Terms and Principles
|
6
|
ARTICLE II AMOUNT AND TERMS OF THE LOANS
|
6
|
|
Section 2.1
|
Loan Commitment.
|
6
|
Section 2.2
|
Borrowing Procedure
|
7
|
Section 2.3
|
Optional Reduction and Termination of Loan Commitment
|
7
|
Section 2.4
|
Repayment of Loans
|
7
|
Section 2.5
|
Prepayment
|
7
|
Section 2.6
|
Interest on Loans
|
7
|
Section 2.7
|
Computation of Interest
|
8
|
Section 2.8
|
[Reserved]
|
8
|
Section 2.9
|
Payments Generally
|
8
|
Section 2.10
|
Taxes
|
10
|
Section 2.11
|
Illegality
|
10
|
Section 2.12
|
Defaulting Lenders
|
10
|
Section 2.13
|
Independent Obligations
|
10
|
Section 2.14
|
Maintenance of Loan Account; Statements of Obligations
|
11
|
ARTICLE III CONDITIONS PRECEDENT TO LOANS
|
11
|
|
Section 3.1
|
Conditions to Effectiveness
|
11
|
Section 3.2
|
Conditions to Making of each Loan
|
11
|
ARTICLE IV REPRESENTATIONS AND WARRANTIES
|
12
|
|
Section 4.1
|
Corporate Existence; Compliance with Law
|
12
|
Section 4.2
|
Power; Authorization; Enforceable Obligations
|
12
|
Section 4.3
|
No Legal Bar
|
12
|
Section 4.4
|
No Material Litigation
|
12
|
Section 4.5
|
No Default
|
12
|
Section 4.6
|
Use of Proceeds
|
12
|
ARTICLE V COVENANTS
|
13
|
|
Section 5.1
|
Delivery of Financial Information
|
13
|
Section 5.2
|
Notice of Default
|
13
|
Section 5.3
|
Conduct of Business and Maintenance of Existence, etc
|
13
|
ARTICLE VI EVENTS OF DEFAULT
|
13
|
|
Section 6.1
|
Events of Default
|
13
|
ARTICLE VII MISCELLANEOUS
|
15
|
|
Section 7.1
|
Notices.
|
16
|
Section 7.2
|
Waiver; Amendment
|
16
|
Section 7.3
|
Expenses; Indemnification
|
16
|
Section 7.4
|
Successors and Assigns
|
17
|
Section 7.5
|
Governing Law
|
18
|
Annex A
|
Loan Commitments
|
Exhibit A
|
Notice of Borrowing
|
Exhibit B
|
Form of Assignment and Acceptance
|
Exhibit C
|
Tax Certificates
|
Schedule A-1
|
Agent's Account / Lender Account
|
If to the Borrower:
|
525 Okeechobee Blvd
Suite 1770
West Palm Beach, FL 33401
Attn: Thomas Geoffroy
Email: Tom@advancedflowercapital.com
Phone: 561-510-2349
|
If to the Agent or AFC Lenders:
|
525 Okeechobee Blvd
Suite 1770
West Palm Beach, FL 33401
Attn: Thomas Geoffroy
Email: Tom@advancedflowercapital.com
Phone: 561-510-2349
|
with copies to:
|
Rutan & Tucker, LLP
611 Anton Boulevard, 14th Floor
Costa Mesa, CA 92626
Attn: William F. Meehan
Email: wmeehan@rutan.com
|
AFC GAMMA, INC.
as Borrower
|
|||
By:
|
/s/ Thomas Geoffroy
|
||
Name:
|
Thomas Geoffroy
|
||
Title:
|
Chief Financial Officer
|
||
AFC FINANCE, LLC
as Agent
|
|||
By:
|
/s/ Leonard M. Tannenbaum
|
||
Name:
|
Leonard M. Tannenbaum
|
||
Title:
|
CEO
|
||
AFC FINANCE, LLC
as Lender
|
|||
By:
|
/s/ Leonard M. Tannenbaum
|
||
Name:
|
Leonard M. Tannenbaum
|
||
Title:
|
CEO
|
||
GAMMA LENDING HOLDCO LLC
a Delaware limited liability company
as Lender
|
|||
By:
|
/s/ Jonathan Kalikow
|
||
Name:
|
Jonathan Kalikow
|
||
Title:
|
Authorized Signatory
|
Lender
|
Loan Commitment
|
AFC FINANCE, LLC
|
$30,000,000
|
JON KALIKOW
|
$10,000,000
|
TOTAL
|
$40,000,000
|
Exhibit 21.1
List of Subsidiaries of the Registrant
None.